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Introductory Chapter: Thesis Overview 
 This thesis consists of two chapters (1) a systematic review which explores older 
women’s decision-making in relation to medical treatments; (2) an empirical paper which 
explores the decision-making processes of women aged sixty or above who have been offered 
Electroconvulsive Therapy (ECT). The empirical paper has been written for a planned 
publication in the Journal of Geriatric Psychiatry and Neurology and has therefore been 
written in line with their authors guidelines. These can be found in Appendix A. Also, in the 
near future the systematic review paper will be prepared for publication in the Journal of Age 
and Ageing and will be formatted in line with their authors guidelines. Currently the 
systematic review is formatted in line with APA formatting guidance.   
 Despite being individual papers, the two chapters aim to explore and obtain a greater 
understanding of older women’s decision-making processes and factors which influence an 
individual’s medical treatment decision-making. Such understanding enables clinicians to 
individualise treatment discussions and enhance educational strategies (Angarita, Elmi, 
Zhang, & Look Hong, 2018). This in turn increases the likelihood of person-centred care, as 
clinicians and service-providers alike are better able to develop and tailor interventions, based 
on their client or patient’s goals, values and treatment preferences which positively influences 
patient satisfaction and clinical outcomes (Angarita et al., 2018; Ciambrone, 2006). 
 Throughout both papers, the researchers acknowledge that there is no consensus on 
what defines an “older woman” (Angarita et al., 2018). However, for the purpose of both the 
systematic review and the empirical paper a threshold of sixty years or above was used to 
classify the population being studied as ‘older’. This threshold was chosen as the most recent 
dataset published by the ECT accreditation service (ECTAS) indicated that 1073 out of 1821 
individuals to receive acute courses of ECT between April 2016 and March 2017 were aged 
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sixty or above and the mean age of individuals to receive ECT within the same time frame 
was sixty-one years, the mode was seventy years and the median was sixty-four years, 
respectively (Buley, Copland, & Hodge, 2017). The researchers also wished to maintain 
consistency, where possible, across the two chapters although, they acknowledge that across 
the papers included within the systematic review authors use thresholds of sixty-five and 
seventy years to classify the population as ‘older’ (Husain, Collins, Reed, & Wyld, 2008; 
Schonberg et al., 2014). 
 Until this point, there has been a lack of synthesised data exploring factors which 
influence older women’s treatment decision-making, when they are faced with a decision 
around whether to receive or decline a medical treatment. The systematic review therefore 
identified, appraised and synthesised the existing literature which explores this phenomenon. 
A systematic search was conducted across six electronic databases and a total of nine papers 
were identified for review, with all but one paper exploring decision-making within the 
context of older women’s cancer treatment. The findings of this review suggested that the 
degree to which older women wish to be involved in their medical treatment decision-making 
varies between individuals. The review also highlighted a range of factors which influence 
this process.  Thus, due to the individual and personal nature of older women’s medical 
treatment decision-making, it was recommended that clinicians take time to work with an 
individual to explore their concerns, values and personal circumstances to understand how 
the interplay between such factors influences their treatment decision-making as this is likely 
to improve collaboration and encourage a more person-centred approach. Several 
recommendations for future research were also made based on the findings of this review, 
particularly as throughout the review the researchers were only able to access research 
relating primarily to older women’s cancer treatment decisions and this limits the conclusions 
7 
Older Women’s Decision Making in the Context of Medical Treatments 
 
 
 
that can be made in relation to older women’s medical treatment decision-making more 
generally.  
 The empirical paper explored the personal stories of seven females who had been 
offered ECT after they had become sixty years of age, in order to gather an increased 
understanding of their decision-making processes and factors which influenced their 
decision-making around the treatment. Data collected via seven individual interviews was 
analysed using Narrative Analysis as this allowed the researchers to explore each 
participants’ own story, as influenced by any personal, ethical, social or political issues that 
the research may bring (Weatherhead, 2011). The research findings were synthesised into a 
grand narrative, or coherent story (Howitt, 2016), which is presented across five chapters 
within the results section of the empirical paper. The grand narrative highlighted a range of 
factors which influence older women’s decision-making around ECT; participants difficulties 
with depression, feelings of desperation and their desire to “get rid” of distress appeared to be 
the most influential of these factors. From the research findings, a model highlighting factors 
which influence older women’s decision making around ECT was developed. Several clinical 
recommendations and recommendations for future research were also made, including, the 
use of robust and comprehensive consent processes throughout an individual’s course of 
ECT, as feelings of desperation and an individual’s perception around their treatment choice 
are noted to influence an individual’s ability to provide informed consent and the 
voluntariness of their decision (Clarke, Barnes, & Ross, 2018; Swift, 2011), and exploring the 
perspectives of family members, friends and carers who support individuals offered ECT.  
 The systematic review, empirical paper and their findings highlight the individualised 
and personal nature of older women’s decision-making within the context of medical 
treatments for both physical and mental health difficulties. Older women’s treatment 
decision-making has largely been neglected within medical and mental health research which 
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in turn is likely to have resulted in clinicians, who work in physical and mental health 
services, making paternalised assumptions around older women’s treatment preferences, their 
preferred decision-making style and their sense of autonomy and empowerment.  Through 
disseminating the findings, and highlighting the clinical recommendations made it is hoped 
that clinicians are encouraged to have more open discussions around the physical and mental 
health treatments available to older women, older women’s treatment preferences, their 
preferred decision-making style and factors which influence their treatment decision-making. 
This in turn is likely to improve the decision-making process experienced by older women 
and support more informed decision-making. It is also hoped that by addressing the 
recommendations for future research, researchers will continue to contribute to the growing 
evidence base relating to older women’s health care decision-making to further increase 
understanding of factors which influence the decision-making process experienced by 
individuals when they are faced with a decision around whether to receive a medical 
treatment for varying physical and mental health concerns.  
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Abstract 
 
Background 
 The population of the United Kingdom (UK) has steadily aged through the latter half 
of the twentieth century, which in turn has increased the risk of individuals experiencing one 
or more chronic health conditions. The growing need for interventions specifically developed 
for an ageing population has therefore been emphasised within the literature alongside the 
importance of identifying the physical and psychosocial phenomenon which influences 
treatment decision-making. Despite this, conflicting information regarding older people’s 
health care decision-making preferences can be found and synthesised data exploring factors 
which influence older women’s medical treatment decision-making is lacking. 
 
Aims  
To identify, appraise, and synthesise the existing literature that explores factors which 
influence the medical treatment decision-making of women aged sixty or above.  
 
Methods 
A systematic review was performed in accordance with Preferred Reporting Items for 
Systematic Review and Meta-analysis Protocols (PRISMA) principles. A search was 
conducted across six electronic databases and in total nine papers were identified for review, 
with all but one study exploring older women’s decision-making within the context of cancer 
care. The quality of the articles identified was assessed through the Quality Assessment Tool 
for Studies with Diverse Design (QATSDD).  
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Results 
 Contrary to assumptions described in the medical literature, the results of this review 
indicated that many older women are keen to be involved in their medical treatment decision-
making and employ a range of strategies to support their decision-making processes. 
However, the degree to which an individual wishes to be involved in such decision-making 
varies between individuals, along with factors found to influence treatment decision-making. 
Nonetheless, the study’s findings highlighted the influence of the recommendations made by 
health care professionals (HCP’s), participants personal circumstances, their knowledge of 
treatments and personal preferences as well as the influence of age-related health and life 
circumstances.  
 
Conclusions 
 Older women’s medical treatment decision-making is a highly personal and 
individualised process. Clinicians supporting older women, therefore, should not make 
assumptions around older women’s treatment preferences or their preferred decision-making 
style. Instead it is recommended that clinicians take time to work with individuals to explore 
their concerns, values, social and personal circumstances to understand how the interplay 
between such factors influences an individual’s treatment decision-making, as this is likely to 
increase collaboration between HCPs and older women, encourage a more person-centred 
approach and improve treatment satisfaction.  
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Introduction 
 ‘Decision-making’; a fundamental and continuous process which impacts daily 
outcomes relates to the mental activities that occur when an individual is presented with 
multiple options (Galotti, 2002; McFall, 2015). The process typically involves a decision-
maker undertaking several tasks including, goal setting, gathering information, decision 
structuring, and making and evaluating a final choice, even for the most minimally complex 
decisions. (Galotti, 2002). However, it is important to note that a decision-maker may 
perform multiple tasks simultaneously, may skip tasks and may perform the tasks in different 
orders, depending on the decision being made (Galotti, 2002).  
 Within health care settings, person-centred care and shared decision-making are 
increasingly advocated as a guide for how assessments, consultations, diagnoses and 
treatments should be performed (Sandman & Munthe, 2010). Shared decision-making, where 
both a patient / service-user and a clinician play an active role in the decision-making process 
around the patient’s treatment, is considered to be a key feature within a person-centred 
approach and has therefore been contrasted with other models of medical decision-making 
such as, paternalism and patient choice alone (Sandman & Munthe, 2010).  
Researchers note that as shared decision-making involves integrating evidence into 
care and treatment discussions it enables patients to be better prepared to make informed, 
evidence-based health care decisions that are aligned with their treatment goals, values, and 
personal preferences (Cohen, 2017). Some of the positive outcomes associated with shared 
decision-making include increased treatment satisfaction and a reduction in unwarranted 
variation in care (Bradley & Green, 2018; Cohen, 2017). A 2014 systematic literature review 
suggested that interventions which support shared decision-making significantly improve 
outcomes for disadvantaged groups although, these findings should be interpreted with 
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caution due to the varying quality and small sample sizes of the reviewed studies (Durand et 
al., 2014). It is, however, important to note that in addition to ethical and clinical arguments, 
there are also economic arguments which support a shared decision-making approach as this 
has been associated with reduced care costs which may be a result of reduced hospitalisation 
and increased adherence to medication (Bradley & Green, 2018; Cohen, 2017). Moreover, 
despite such supporting arguments clinicians should be aware that not all individuals wish to 
participate in their health care decisions. Engaging in shared decision-making generally 
requires knowledge, confidence, self-efficacy and high levels of health literacy (Chung, 
Lawrence, Curlin, Arora, & Meltzer, 2012; Durand et al., 2014). Evidence, therefore, 
suggests that treatment decision-making preferences vary between individuals and although 
many individuals prefer an active role others prefer such role to be more passive (Nicolai et 
al., 2016). With this, clinicians should not assume that shared decision-making is beneficial 
for all individuals as for some providing detailed information around treatment options or 
imposing a choice may significantly increase anxiety and may lead to decisional conflict 
(Nicolai et al., 2016).  
Research exploring the relationship between ageing and decision-making is beginning 
to grow, with some researchers arguing that older adults prefer less autonomy and seek less 
information when making decisions on their own (Reed, Mikels, & Simon, 2014) and others 
suggesting that when faced with more than one option, older adults were more likely to 
choose options that involve shorter time delays or higher probabilities of experiencing an 
interaction with a close social partner (Seaman et al., 2016). There is also conflicting 
evidence around older people’s desire to be involved in their health care decision-making, 
with some researchers suggesting that not all older people wish to engage in a shared 
decision-making process and prefer to simply receive information around their treatment and 
would prefer to participate in a doctor-led decision-making process (Husain, Collins, Reed, & 
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Wyld, 2008; Morgan et al., 2015; Vogel, Helmes, & Hasenburg, 2008). Whereas, for other 
individuals collaboration throughout the decision-making process is highly valued (Thomé, 
Dykes, Gunnars, & Hallberg, 2003). Nonetheless, the literature suggests that older adults 
have historically been less likely to participate in health care decisions and limited attention 
has been paid to how best engage older adults in their health care decision-making processes 
(Elliott et al., 2016; Schulman-Green, Naik, Bradley, McCorkle, & Bogardus, 2006) which in 
turn may negatively influence treatment outcomes and older adults’ well-being, particularly if 
their involvement is a consequence of older adults being less likely to be invited to participate 
in health care decisions, rather than individuals preferring a clinician-directed decision-
making style. 
The population of the United Kingdom (UK) has steadily aged throughout the latter 
half of the twentieth century which in turn has increased the risk of individuals experiencing 
one or more chronic health conditions (Fuller, Mindell, & Prior, 2016; Office for National 
Statistics, 2018) . Researchers have therefore emphasised the growing need for interventions 
which target older people and older women, specifically, however, they argue that such 
interventions cannot be adequately developed without obtaining an understanding of the 
physical and psychosocial phenomena which affect decision-making (Ciambrone, 2006). 
Despite this, synthesised data exploring factors which influence older women’s medical 
treatment decision-making is lacking.  
An increased understanding of factors which influence older women’s medical 
treatment decision-making enables clinicians to individualise treatment discussions with 
patients and enables them to tailor educational strategies, reduces the risk of misinformation 
and has been found to improve a range of outcomes, including patient satisfaction (Angarita, 
Elmi, Zhang, & Look Hong, 2018). This systematic review was therefore conducted to 
identify, appraise, and synthesise the existing literature exploring factors which influence 
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older women’s decision-making around whether to accept or decline a medical treatment. For 
the purpose of this review, a threshold of sixty years or above was used to classify the 
population being studied as ‘older’. However, the reviewers acknowledge that there is no 
consensus on what categorically defines an ‘older woman’ (Angarita et al., 2018).  
 
Review Question 
1. Which factors influence older women’s decision-making around whether to receive or 
decline a medical treatment?  
 
Method  
 Throughout this mixed methods systematic review, a convergent integrated approach 
to synthesis and integration was utilised, as guided by the methodology outlined within The 
JBI Manual of Evidence Synthesis (Aromataris & Munn, 2019).This approach was chosen as 
the review question could be answered by qualitative, quantitative and mixed methodological 
approaches. Also, a convergent integrated approach is reported to provide a better 
understanding of the phenomenon under study as it allows reviewers to ‘sum up’ what is 
known about a target phenomenon and, can therefore direct both future practice and research 
(Lizardo et al., 2019; Sandelowski, Voils, & Barroso, 2006). Throughout this review the 
reviewers (1) used two tables, found in Table 3 and Appendix B, to extract data relevant to 
the review question; (2) ‘qualitised’ quantitative results highlighted within the quantitative 
and mixed methodological studies included in this review; (3) pooled together qualitative and 
‘qualitised’ data based on their similarities in order to produce a set of integrated findings. A 
predetermined protocol which highlighted methods of analysis and inclusion criteria was 
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followed throughout the mixed methods systematic review however, this was not formally 
published. Preferred Reporting Items for Systematic Review and Meta-analysis Protocols 
(PRISMA) guidelines were also followed.  
 
Article Search Strategy 
  Articles were identified through an electrical search within several databases 
including, AMED, APA PsycINFO, CINAHL, MEDLINE, PubMed and Web of Science 
after a comprehensive search strategy was developed through consultation with an NHS 
librarian. The search terms used for each database included the following combinations: (old* 
OR aged OR geriatric OR ag?ing OR elderly) AND (woman OR women OR female*) AND 
(decision making OR decision-making OR decision making process OR decision-making 
process) AND (health OR health care OR healthcare).  
 
Study Selection 
 After conducting the searches outlined above one reviewer (RW) began making 
inclusion decisions based on the review’s eligibility criteria, this process occurred in several 
stages. The reviewer initially removed all duplicate papers before independently reviewing 
the title and abstracts for initial eligibility. Once reasons for exclusion were recorded, the full 
texts of potential studies were reviewed in line with the review’s eligibility criteria. A second 
reviewer (SB) provided support throughout this stage to check reliability of the process. The 
PRISMA diagram, Figure 1, is utilised to highlight the process of screening and identifying 
eligible publications and to ensure transparency (Liberati et al., 2009).  
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Eligibility Criteria 
 The Population, Intervention, Comparison, Outcome and Study type (PICOS) 
framework was used to guide the development of this review’s eligibility criteria. Studies 
were identified for review if they satisfied the following eligibility criteria:  
1) The population under investigation were women aged sixty or above who had been 
faced with a decision around whether to undergo a medical intervention such as 
pharmacotherapy and surgical procedures.  
2) The population under investigation were being treated within westernised countries.  
3) The studies explored participant-reported factors which influenced or were associated 
with their treatment decision-making at the time they were faced with a decision 
around whether to undergo a medical intervention.  
4) The studies used qualitative, quantitative, or mixed methodologies.  
5) The studies were published in English peer reviewed journals from the year 2000 
onwards.  
Studies were excluded from the review if:  
1) The studies involved other age groups or genders and if a subgroup analysis for the 
population of interest was not conducted.  
2) The studies explored older women’s decision-making around non-medical 
interventions, such as physiotherapy or chiropractic interventions. 
3) The studies explored older women’s decision-making around assessment or screening 
procedures, such as mammography.  
4) The studies explored secondary data, such as information recorded within medical 
records.  
5) The studies utilised vignettes to explore hypothetical decision-making  
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6) The studies explored factors associated with participant decision-making style and 
communication preferences in isolation. 
Narrative and systematic reviews, meta-analyses, protocols, dissertations, and case-reports 
were also excluded from this review. Further information highlighting how the PICOS 
framework was used to develop the inclusion and exclusion criteria of this review can be 
found in Table 1.  
 
Table 1 
The Review’s Inclusion and Exclusion Criteria in line with the PICOS Framework 
PICOS Inclusion Criteria 
Population • Women aged sixty or above.  
• Women who had been offered a medical treatment within a 
Westernised country 
Interest • Factors which influence medical treatment decision-making  
Context • Medical treatments or medical interventions 
Study Type  • Qualitative studies which were published in a peer reviewed 
journal since the year 2000 
• Quantitative studies which were published in a peer reviewed 
journal since the year 2000 
• Mixed methodological studies which were published in a peer 
reviewed journal since the year 2000 
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• Studies published in the English language 
 
Data Extraction  
 At the point of data extraction, reviewers were not blinded to each study’s author or 
the source of publication. One reviewer (RW) independently reviewed the identified studies 
and extracted qualitative and quantitative data by using the tables outlined in Table 3 and 
Appendix B. The data extracted included specific details which related to (1) the study’s 
characteristics, including the author, year of publication and the country the study was 
conducted within; (2) participant information and characteristics, including the number of 
participants, their age and ethnicity; (3) study design and contextual information including 
data collection techniques and methods of analysis; (4) participant recorded information 
relating to their decision-making at the time they were faced with a decision around whether 
to undergo a medical intervention. Further details relating to the data extracted can be found 
in Table 3 and Appendix B.   
 
Data Transformation 
 Quantitative data was converted into ‘qualitised data’ as this allowed the reviewers to 
compare and contrast qualitative and quantitative findings. Throughout this process 
quantitative data, highlighted within quantitative and mixed methodological studies, was 
transformed into a textual description or narrative interpretation, through repeated 
examination and discussion between the two reviewers (RW and SB), in a way which 
answered the review question. Numerical figures or quantities highlighted within quantitative 
data were therefore removed throughout the ‘qualitising’ process to allow the data to be 
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understood as standalone sentences which could be understood and compared against 
qualitative data. Table 3 includes two examples of qualitised data which demonstrate how the 
quantitative findings of Takase-Sanchez et al. (2015) were transformed into a textual 
description which could be compared against the qualitative findings of other studies.  
 
Data Synthesis and Integration 
 A convergent integrated approach, as described by the JBI methodology for mixed 
methods systematic reviews (Lizardo et al., 2019) was used throughout this review as this 
allowed the reviewers to group eligible studies for synthesis by their findings and better 
highlights findings which answer the same research question and those that address the same 
aspects of a target phenomenon (Sandelowski et al., 2006). Qualitative data was therefore 
assembled with ‘qualitised’ data and pooled together based on their similarity in meaning in 
order to produce a set of integrated findings which highlight factors which influence older 
women’s medical treatment decision-making. These integrated findings are highlighted 
within the results section of this review under relevant subject headings.  
 
Quality Assessment 
 To determine the quality of the individual studies identified within this review, each 
study was scored using the Quality Assessment Tool for Studies with Diverse Design 
(QATSDD) (Sirriyeh, Lawton, Gardner, & Armitage, 2012). This 16-item tool was chosen as 
it allows reviewers to compare studies which utilise qualitative, quantitative, and mixed 
methods designs. The tool has also been assessed to determine its reliability and validity 
when used by health services researchers in the disciplines of psychology, sociology, and 
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nursing. Cohen’s Kappa was used to assess test-retest reliability with scores falling within the 
good and substantial ranges (Sirriyeh et al., 2012).  
 When using the QATSDD reviewers are required to award each research paper a 
score between zero and three for each of the relevant criteria; fourteen of these criteria apply 
to qualitative studies, fourteen apply to quantitative studies however, all sixteen apply where 
studies have used a mixed methods design (Sirriyeh et al., 2012). A total quality score of up 
to forty-two can be obtained for qualitative and quantitative studies. A quality score of up to 
forty-eight can be obtained for studies which utilise a mixed methods approach (Sirriyeh et 
al., 2012). Each of the studies identified were reviewed by two reviewers (RW and SB). In 
line with recommendations made by Sirriyeh et al. (2012) each eligible paper was reviewed 
by the two reviewers independently in order to obtain an overall quality score for each paper. 
Any discrepancies between the reviewers’ scoring throughout the quality assessment were 
resolved through later discussions. A summary of each paper’s quality assessment can be 
found in Table 2.  
 
Results  
Study Selection 
 A total of 3,451 papers were identified through database searching and after 
duplicates were removed 2,730 were screened for eligibility. Of the 2,730 papers screened 
2,680 failed to meet the reviews eligibility criteria based on their title and abstract alone. 50 
articles were assessed for eligibility by review of the full text. 43 of these studies were 
excluded and 7 studies were included in the synthesis. An additional 2 papers were identified 
by reviewing the reference lists of the 7 eligible studies. In total 9 papers were included in the 
review. A PRISMA flow diagram highlighting this process can be found in Figure 1.  
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Figure 1- PRISMA Flow Diagram Highlighting Study Selection  
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Table 2 
Quality assessment of studies using the QATSDD tool                                                                                                                                                    
Selected articles identified by author and year. The score awarded to each criterion relate to 0=Not at all, 1=Very slightly, 2=Moderately, 
3=Complete. 
25 
Older Women’s Decision Making in the Context of Medical Treatments 
 
 
 
Quality Assessment  
 The outcome of each article’s methodological quality assessment is presented within 
Table 2. This indicates that the nine articles included within this review are of varying quality 
and notes that six out of the nine articles provided minimal detail which highlights the 
strengths and limitations of the study. In contrast to this, the quality assessment demonstrated 
that the majority of studies provided a clear description of the research setting, all at least 
made broad reference to the study’s aims and objectives in the main body of the report and 
most demonstrated an appropriate fit between the research question and the method of 
analysis utilised. On the whole, the eligible articles were deemed to be of reasonable quality, 
as measured by the QATSDD, and their quality was sufficient enough for each article to be 
included within this mixed methodological review. Although, it is important to note that 
caution was taken by the reviewers when synthesising the results in order to account for 
varying quality highlighted throughout the quality assessment.  
 During the quality assessment, the QATSDD highlighted several limitations with the 
paper written by Ciambrone (2006), this was therefore considered to have the poorest quality 
out of the nine papers included in this review.  These limitations included the author not 
demonstrating whether the study’s sample size had been considered in terms of analysis, not 
describing their rationale for the choice of data collection tool(s), them providing poor 
justification for the analytical method selected and them not highlighting the reliability of the 
analytical process. Additionally, the paper written by Ciambrone (2006), along with the 
papers written by Husain et al. (2008), Lifford et al. (2015), Morgan et al. (2015), Pieters et 
al. (2012), Schonberg et al. (2014) and Takase-Sanchez et al. (2015), did not demonstrate 
evidence of service-user involvement in their design. This was surprising to the authors, 
particularly as the area being explored related to decision-making, and was considered to be a 
major limitation of seven of the nine papers included in this review.  
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Study Characteristics  
 Out of the nine reviewed studies, five were conducted in the USA,  three were 
conducted in the UK and one was conducted in Canada and all were published in academic 
journals between 2001 and 2015. All of the studies aimed to explore and identify factors 
which influenced or were associated with older women’s treatment decision-making, with the 
majority of studies exploring such phenomenon within the context of breast cancer treatment. 
However, one study also explored older women’s treatment decision-making in relation to 
either breast or gynaecologic cancer and a final study explored patient-reported reasons for 
selecting obliterative surgery for the treatment of pelvic organ prolapse. Several of the studies 
also had additional aims which included (1) exploring factors associated with older women’s 
breast cancer surveillance decision-making and adherence; (2) identifying the attitudes of 
older women in relation to primary endocrine therapy (PET) and surgery in the context of 
breast cancer treatment; (3) understanding the experiences of older women who have 
undergone PET or surgery as a treatment for breast cancer; (4) exploring the concordance 
between health care professionals (HCP’s) and patient views regarding the process of 
decision-making in relation to treatment of operable breast cancer; (5) understanding how 
older women’s decision-making processes may contribute to treatment decision regret or 
satisfaction.  
 The sample size varied across studies, in line with each study’s methodology. The 
sample size of the qualitative studies included in this review ranged between 15 and 35. The 
two quantitative studies had sample sizes of 198 and 77, respectively. Moreover, the sample 
size of the two mixed methodology studies were 729 and 70 although, in the paper written by 
Morgan et al. (2015) only 33 women who had undergone treatment for breast cancer 
participated in qualitative interviews in addition to an initial questionnaire relating to their 
decision-making preferences.  
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 In relation to analysis, three of the qualitative studies which were written by 
Ciambrone (2006), Pieters et al. (2012) and Sinding et al. (2005) drew upon grounded theory 
to analyse the data obtained through qualitative interviews. The paper written by Husain et al. 
(2008) used framework analysis and within their paper Lifford et al. (2015) used the Coping 
in Deliberation (CODE) framework to gain insight into decision-making and coping 
processes. Cyran et al (2001) and Takase-Sanchez et al. (2015) used quantitative 
methodologies within their articles which involved bivariate analyses by means of χ² tests, t-
tests or analysis of variance, multivariate logistic regression and spearman rank correlation 
coefficients. The paper written by Morgan et al. (2015) used mixed methodologies; the 
concordance between participants’ preferred and actual decision-making preferences was 
assessed using Cohen’s Kappa, associations between age, treatment and decision making 
style were identified using χ² tests and framework analysis was used to analyse data gathered 
through qualitative interviews. Finally, Schonberg et al. (2014) utilised χ² tests, a two-sample 
t-test or the Wilcoxon Rank-Sum test for the quantitative component of the study and 
progressive coding techniques were used to identify themes within the qualitative component. 
 
Participant Characteristics 
 In line with the review’s eligibility criteria, participants in all nine articles were 
women who were aged sixty or above. Most papers reported the age range of participants at 
the time they participated in the study, with participant ages ranging between sixty-five and 
ninety-eight years. Most papers also reported the average age of participants at the time they 
participated in this study, by highlighting either the “average age”, median age or mean age; 
such figures ranged between seventy-six and eighty-three years. However, the papers written 
by Schonberg et al. (2014) and Sinding et al. (2005) did not report the full age range of 
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participants and did not provide information around the mean of participants. Instead the 
authors highlighted age brackets of interest such as, ‘65 to 74 years’ and then ‘74+ years’. 
Also, rather than reporting the age of participants at the time they took part in the study, 
Cyran et al. (2001) reported the age range and mean age of participants at the time they had 
received a diagnosis of breast cancer, with participants being between sixty-five and eighty-
four years and had a mean age of seventy-two years at the time they were diagnosed with 
breast cancer. 
All studies reported either the time frame between participants receiving a physical 
health diagnosis, them completing treatment or undergoing a particular surgical procedure. 
Of the eight papers that reported the timeframe between participants receiving a physical 
health diagnosis and later participating in the research study, seven reported that such time 
frame was between three months and ninety-six months. The exception to this was the paper 
written by Ciambrone (2006) which noted that most participants received a diagnosis of 
breast cancer six years prior to participating in the research study. However, this time frame 
ranged from two years to twenty years. Pieters et al. (2012) reported that the mean time 
between participants completing their primary treatment for primary-stage breast cancer and 
participating in their research interview was eight and a half months and although Takase-
Sanchez et al. (2015) did not report the duration between participants undergoing obliterative 
surgery as a treatment for pelvic prolapse and them later taking part in the study they did 
however, explore the time since such procedure and its relationship between surgical decision 
regret.  
Six of the nine papers eligible for this review included information relating to 
participants’ ethnicity and highlighted a poor representation of individuals from Black, Asian 
and Minority Ethnic (BAME) backgrounds. Across the six studies individuals who self-
identified as white or Caucasian represented between 61% and 100% of participants. Also, of 
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the three studies which included no information regarding participant ethnicity Ciambrone 
(2006) was the only author to acknowledge that studies exploring the decision-making of 
“women of colour” are needed.  
Finally, the studies included in this review reported participant information relating to 
their educational status and their marital status. Six out of the nine studies included 
information regarding participants educational status.  The papers written by Pieters et al. 
(2012), Sinding et al. (2005) and Takase-Sanchez (2015) provided the most detail in this 
domain by highlighting the proportion of people who had obtained grade 8 education or less, 
had completed some or all of their high school education, had completed some college, had 
obtained an associate’s degree, a bachelor’s degree or a graduate degree. In relation to 
participant marital status, six studies provided at least some information in relation to the 
proportion of participants who were married, had been widowed, were living alone or had 
never been married. However, Cyran et al. (2001) did not report a full data set in relation to 
this, suggesting that not all participants provided information relating to their marital status. 
Within their articles Lifford et al. (2015), Morgan et al. (2015) and Sinding et al. (2005) did 
not report data relating to participant marital status. Instead, Sinding et al. (2005) provided 
detail around participant household status and indicated the proportion of participants who 
lived alone, lived with at least one other person, or lived within a senior resident’s facility.  
 
Treatment Characteristics 
 All of the nine studies included in this review had interviewed or surveyed women 
who had decided on or completed their treatment. The majority of studies explored the 
decision-making in the context of breast cancer treatment, with participants either being 
offered or undergoing breast conserving surgery or lumpectomy, radiation therapy, 
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mastectomy, chemotherapy, PET, wide local excision, PET or surgery with endocrine therapy 
and proton therapy across the seven papers. Sinding et al. (2005) explored decision-making in 
the context of both breast and gynaecologic cancer however, it does not report the treatments 
offered to older women or those which they had received. Moreover, Takase-Sanchez et al. 
(2015) specifically explored factors which influenced older women’s decision to receive 
obliterative surgery for the purpose of pelvic organ prolapse. 
 
Decision-Making Styles 
 Three types of decision-making styles were described by researchers throughout the 
nine articles including clinician-based decision-making, patient-based decision-making and 
shared decision-making approaches. Morgan et al. (2015) explored both participants 
preferred and actual decision-making styles and identified a moderate agreement between the 
two phenomena. The authors also noted that such styles were associated with participants 
final treatment type, with surgery being associated with clinician-centred decisions and PET 
with patient-centred decisions. Several papers also reported participants actual decision-
making style and their perceived involvement around their treatment decision-making; 
Schonberg et al. (2014), for example, reported that 41% of participants reported making 
treatment decisions with physicians and their family, 34% reported sharing their decision 
with their clinician and 17% made their final treatment decision alone. Similarly, Pieters et al. 
(2012) note that although participants felt supported by their physicians, many had felt 
confident that they had made their own treatment decisions and had emphasised that they had 
not made treatment decisions just to gain their physician’s approval. In contrast to this, 
Ciambrone (2006) writes that 60% of participants perceived their treatment decision to be 
driven by their physician, Cyran et al. (2001) noted that 24% of participants recalled that they 
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did not have a choice of procedure and Lifford et al. (2015) reported that many participants 
did not perceive that they had a choice to make, because they were either not offered a choice 
by their health care professional or they believed that the decision was instantly obvious. 
Specifically, Ciambrone (2006) noted how participant’s language was indicative of their non-
participation in treatment decision-making as women emphasised how they “did what they 
told me to do”. 
Husain et al. (2008), Sinding et al. (2005) and Takase-Sanchez et al. (2015) did not 
specifically report participants preferred or actual decision-making style and did not report 
how participants experienced their involvement in their treatment decision-making. However, 
Husain et al (2008) reported that participants relied heavily on ‘expert’ medical advice when 
deciding on their treatment and Takase-Sanchez et al. (2015) highlighted the influence of 
clinicians as “a need to follow my doctor’s recommendations” was concluded to be the most 
influential factor when participants were faced with a  decision around whether to receive 
obliterative surgery. Moreover, Sinding et al. (2005) noted that for some individuals, making 
treatment decisions which were not aligned with the advice received by their clinician 
resulted in awkward interactions with their health care professionals and negatively 
influenced their care and treatment.  
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Participant-reported factors which influence treatment decision-making  
Table 3 
 Factors reported by participants as influencing their treatment decision-making 
Participant-
reported factors  
Illustrative Quote  Contributing 
studies  
Perceptions of 
risk  
“Cancer immediately was associated with death, uncertainty (e.g., “What 
are they going to do to me?”) and suffering”(Pieters et al., E12).  
 
“Women’s cognitive appraisals of breast cancer were mainly focussed on 
their chances of survival and the potential for cancer control or cure” 
(Lifford et al., 2015, p7) 
 
Ciambrone 
(2006), Cyran 
et al. (2001), 
Husain et al. 
(2008), Lifford 
et al. (2015), 
Pieters et al. 
(2012), 
Schonberg et 
al. (2014). 
 
Physician 
recommendations  
“Most women described their treatment as their physician’s choice and 
they were happy to leave the decision-making to the “experts”” 
(Ciambrone, 2006, p36) 
 
“A need to “follow my doctor’s recommendations” made the most 
difference in selecting obliterative surgery” (Takase-Sanchez et al., 2015, 
p327).   
 
 
Ciambrone 
(2006), Cyran 
et al. (2001), 
Husain et al. 
(2008), 
Morgan et al. 
(2015), 
Schonberg et 
al. (2014), 
Sinding et al. 
(2005), 
Takase-
Sanchez et al. 
(2015).  
 
Faith in their 
physician’s 
judgement 
 
“These women had confidence in their oncologists and trusted that they 
would make the best treatment decisions for their individual cases  
(Ciambrone, 2006, p38) 
Ciambrone 
(2006), Pieters 
et al. (2012), 
Schonberg et 
al. (2014). 
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The perspectives 
of significant 
others  
“Many women were pleased that their significant others did not have 
much to say regarding treatment as they felt it would make their life more 
difficult” (Ciambrone, 2006, p37) 
 
 
Ciambrone 
(2006), Lifford 
et al. (2015), 
Pieters et al. 
(2012), 
Schonberg et 
al. (2014). 
 
Knowledge of 
treatments and 
personal 
preferences  
“Two of the women, however, did voice a strong preference for a 
particular treatment option regardless of the advice from the medical 
team. They based their decision on the experiences of close family 
members who themselves had suffered from breast cancer” (Husain et al., 
2008, p413).  
 
“Most formed a preference relatively quickly based on their past 
experiences and personal goals and values” (Lifford et al., 2015, p7).  
 
 
Ciambrone 
(2006), Husain 
et al. (2008), 
Lifford et al. 
(2015), 
Morgan et al. 
(2015), Pieters 
et al. (2012) , 
Schonberg et 
al. (2014), 
Takase-
Sanchez et al. 
(2015). 
 
 
Attitudes towards 
hospitalisation 
and surgery 
 
“Reasons why they [participants] had chosen PET, other than that it was 
the doctor’s recommendation included having undergone painful biopsies 
and consequently not wanting any further interventional procedure” 
(Husain et al., 2007, p17).  
 
Cyran et al. 
(2001), Husain 
et al. (2008), 
Lifford et al. 
(2015). 
 
Co-morbidities 
and perceptions 
around health, age 
and strength 
“Some women considered whether they were strong or healthy enough to 
recover from surgery and explored whether there were additional coping 
strategies they could employ” (Lifford et al. 2015, p9). 
 
“Participant’s narratives revealed how age-related health and life 
circumstances, intersecting with key features of cancer care and broader 
social structures affecting older people, shaped treatment decisions and 
experiences of treatment” (Sinding et al., 2005, p1171).  
 
Husain et al. 
(2008), Lifford 
et al. (2015), 
Morgan et al. 
(2015), 
Schonberg et 
al. (2014), 
Sinding et al. 
(2005). 
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Potential side 
effects and how 
these may 
influence 
participants’ 
quality of life 
“The most important aspect of treatment outcome for these women 
appeared to be the ability to carry on life as before” (Husain et al., 2005, 
p414) 
 
“Another patient’s decision to forego chemotherapy was driven by 
concern that side effects would jeopardise her ability to continue living at 
home independently, which for her was an overriding priority” (Sinding et 
al., 2005, p1172).  
 
Ciambrone 
(2006), Husain 
et al. (2008), 
Lifford et al.  
(2015), 
Morgan et al. 
(2015), 
Schonberg et 
al. (2014), 
Sinding et al. 
(2005). 
 
Personal 
Circumstances 
“Clinicians frequently were unaware of these personal characteristics, 
such as women who were caregivers of spouses with dementia, that had a 
profound effect on decision-making (Pieters et al., 2012, E16) 
 
“Patient-reported reasons that predicted more satisfaction with the 
decision for obliterative surgery included “No longer sexually active 
and/or did not plan to be” (Takase-Sanchez et al., 2015, p328) 
 
Pieters et al. 
(2012), 
Schonberg et 
al. (2014), 
Sinding et al. 
(2005), 
Takase-
Sanchez et al. 
(2015).  
Practicalities of 
receiving 
treatment  
“Other women considered their lack of financial and social support when 
they made decisions” (Pieters et al., 2012, E16) 
 
“A concern with “getting around” threaded through participants’ accounts 
and drew attention to practical aspects of cancer care associated with 
older age” (Sinding et al., 2005, p1173) 
Pieters et al. 
(2012), 
Schonberg et 
al. (2014), 
Sinding et al. 
(2005). 
  
As demonstrated in Table 3, a range of factors were reported by participants as 
influencing their treatment decision-making, including participant perceptions of risk, the 
advice of their HCP’s, trust, the perspectives of significant others, personal knowledge, 
experience and treatment preferences, the negative consequences associated with particular 
treatments, co-morbid health conditions, attitudes towards hospitalisation and surgery and 
participant’s personal and social circumstances.  
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 Participant Thoughts and Feelings After Receiving a Physical Health Diagnosis. 
 Husain et al. (2008) and Schonberg et al. (2014), who both explore treatment 
decision-making in the context of breast cancer, describe the varying experiences of 
participants at the time they received a diagnosis of breast cancer. On hearing their diagnosis, 
Husain et al. (2008) note that the opinions expressed by participants was varied, with some 
individuals being unsurprised at hearing the diagnosis, some accepting that they had already 
had a long life and others being fearful and anxious due to the potential implications of the 
cancer diagnosis. Husain et al. (2008) and Pieters et al. (2012) noted that for participants 
cancer was associated with death, uncertainty, suffering and leaving loved ones behind. 
Across the paper’s participants, therefore, described an urgency to receive treatment in order 
to get rid of the cancer as soon as possible, prevent cancer spread and reduce the risk of re-
occurrence. Risk was also a factor considered by the participants involved in Takase-Sanchez 
et al’s. (2015) study; minimising surgical risks was reported as a reason to undergo such 
treatment.  
  
The Influence of HCPs. 
Participants spoke of how their HCP played a role in their decision-making. Several 
participants involved in the study conducted by Morgan et al. (2015) stated that they wanted 
their clinician to make recommendations around their treatment. Similarly, Cyran et al. 
(2001) highlighted that physician recommendations were reported by 41% of participants as 
influencing their decision to undergo a mastectomy procedure and 37% of participants who 
underwent a lumpectomy. Similarly, “To follow my doctor’s recommendations” was reported 
as making the most difference in participants decision to undergo obliterative surgery 
(Takase-Sanchez et al., 2015). Moreover, Schonberg et al. (2014) and Sinding et al. (2005) 
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highlighted how participants had felt pulled by their HCPs judgement and felt the ‘shoud of 
their physician’s recommendations.  
 Participants involved in the studies conducted by Ciambrone (2006), Pieters et al. 
(2012) and Schonberg et al. (2014) spoke of how they trusted and had faith in their HCPs 
recommendations. Some individuals described how they trusted their clinician with their life 
(Ciambrone, 2006) and others reported how they had faith with whatever the surgeon had 
told them and how they had left their decision-making up to the doctor (Schonberg et al., 
2014). Additionally, Pieters et al. (2012) detailed how participants determined the 
trustworthiness of HCPs and care providers and noted that this was influenced by their 
experience of interacting with HCPs, whether HCPs were able to provide satisfactory 
answers to participants’ questions, and whether the power balance was noted during 
consultations. In particular, participants appreciated that physicians did not form a coalition 
with their spouse or support person when such individuals accompanied them to their 
appointment, but instead primarily related with themselves and specifically provided them 
with treatment options. Pieters et al. (2012) reported how participants deeply valued the 
empowerment and agency that they had received whilst relating with the surgeon.  
  
The Influence of Significant Others. 
The influence of participant’s significant others on the older women’s decision-
making varied across the papers. Pieters et al. (2012) and Schonberg et al. (2014) noted that 
the perspectives of significant others were helpful for some participants, as individuals 
involved in their studies described how it was “important for women to get together and talk” 
and others described how their family members input had helped to confirm their decisions. 
However, in contrast to this Ciambrone (2006) reported that some individuals had described 
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themselves as pleased that their significant others did not have much to say with regards to 
their treatment and preferred informal support systems to provide emotional support rather 
than consultation. Moreover, some individuals involved in Pieters et al’s. (2015) study 
described how their support systems would pressurise them into asking their HCPs questions 
and explained that this was often unhelpful for them as often they did not know what 
questions to ask.  
 Across seven of the nine articles, participants expressed treatment preferences which 
were influenced by their own treatment experiences, the experience of close friends and 
family members, their gut instinct and knowledge of their own personal goals and values 
(Ciambrone, 2006; Husain et al., 2008; Lifford et al., 2015; Morgan et al., 2015; Pieters et al., 
2012; Schonberg et al. 2014; Takase-Sanchez et al., 2015). Lifford et al. (2015) described 
how participants formed treatment preferences relatively quickly and Ciambrone (2006) 
noted how respondents knew the types of treatment they did not want and based their 
decisions on this. Participant attitudes towards hospitalisation and surgery as well as the 
potential implications of undergoing a particular procedure also influenced participants’ 
treatment decision-making. Husain et al. (2008) noted that participants all had previous 
experience of hospitalisation, and many had undergone painful biopsies which influenced 
their wish to avoid further surgical procedures. Similarly, in relation to breast cancer 
treatment participants spoke of their desire to keep their breast, fear of being left disfigured 
and concerns around post-operative scaring and hear thinning when considering their 
treatment options (Cyran et al., 2001; Husain et al., 2008; Lifford et al., 2015) . However, 
Husain et al., (2008) noted that participants involved in their study had chosen to undergo 
less invasive treatments, such as PET, as they were aware that they could later undergo 
surgical procedures.  
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Age-Related Health and Life Circumstances.  
 Finally, Sinding et al. (2005) explain how participant data revealed how age-related 
health and life circumstances alongside key features of care and broader social structures 
which affect older individuals had shaped treatment decision-making, a statement which 
applies to all of the papers included in this review. The influence of co-morbidities, which for 
some participants had pre-dominated their thoughts, had to be taken into consideration 
(Husain et al. 2008). Participants’ perceptions around their age, health and strength were also 
influential, as some individuals described themselves as too old or too frail to undergo or 
recover from particular treatments and others weighed up their changes of survival in 
addition to treatment side-effects (Lifford et al., 2015; Morgan et al., 2015; Schonberg et al., 
2014). Some participants emphasised that the risk of side-effects “weren’t worth it” at their 
age (Ciambrone, 2006) and across several papers participants considered how their quality of 
life would be affected and associated this with their ability to carry on as before, their 
independence, their ability to cope with tasks of daily living and their ability to enjoy hobbies 
(Husain et al., 2008; Lifford et al., 2015; Morgan et al., 2015; Schonberg et al., 2014; Sinding 
et al., 2005). Additionally, some individuals emphasised that they had prioritised their quality 
of life over quantity of life (Morgan et al., 2015; Schonberg et al., 2014). Moreover, 
participants considered the practicalities of treatment and how treatment decisions would 
affect significant others. Pieters et al. (2012) and Schonberg et al. (2014) noted how 
participants had caring responsibilities for their spouses and grandchildren so would therefore 
try and make decisions which were in the best interest of loved ones. Schonberg et al. (2014) 
also raised issues around the practicalities of receiving treatment, particularly in relation to 
the availability of transportation and financial costs. For many women they relied on 
significant others to support them to hospital and whilst they were receiving care. However, 
many individuals disliked being a burden on others and some participants emphasised how 
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participants felt the need to protect vulnerable loved ones from frank discussions with their 
clinicians (Husain et al., 2008; Lifford et al., 2015; Pieters et al., 2012; Sinding et al., 2005). 
 
Discussion  
 This systematic review explored and obtained a greater understanding of factors 
which influence the medical treatment decision-making of older women in relation to a range 
of health conditions. It has previously been demonstrated that such understanding can enable 
clinicians to provide more person-centred care, which in turn can improve clinical outcomes 
and patient satisfaction (Angarita et al., 2018). Similarly, scarcity of evidence regarding the 
perspectives and experiences of older women is likely to result in HCPs making paternalistic 
assumptions around older women’s treatment preferences (Chouliara et al., 2004).  
Following a systematic search nine studies were identified for review, with eight of 
these studies exploring older women’s treatment decision-making within the context of 
cancer care. Across the nine papers, a range of factors were identified as influencing older 
women’s medical treatment decision-making including the recommendations made by HCPs, 
participant’s personal circumstances and their knowledge of treatments and personal 
preferences. The studies eligible for this review also highlighted the influence of age-related 
health and life circumstances and demonstrated how factors such as co-morbidities, the risk 
of side-effects, perceptions around age, health and strength, caring responsibilities and an 
individual’s desire to remain independent, maintain their current quality of life and avoid 
burdening others, had influenced their decision to either receive or decline treatment. The 
nine papers also demonstrated  the wide range of strategies employed by older women when 
they are faced with a decision around whether to receive a medical treatment, including 
drawing upon the advice of their clinician, speaking to loved ones and considering their 
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advice and medical treatment experiences and considering their own goals and preferences. 
Thus, emphasising the truly personal nature of medical treatment decision-making.  
Despite older adults being reported to have less involvement in clinical decision-
making in comparison to other populations (Schulman-Green et al., 2006) the findings of this 
review highlighted involvement in three types of decision-making styles including clinician-
based decision-making, patient-based decision-making and shared decision-making 
approaches, which often depended on their personal preferences. However, across the nine 
papers the influence of HCPs was highlighted, as a ‘need’ to follow physician’s 
recommendations was described alongside the pull of a HCPs judgement. Pieters et al. (2012) 
noted that many individuals found their HCPs recommendations helpful as they had trusted 
their clinician and had experienced positive doctor-patient interactions although for others 
this may have been influenced by paternalistic views (Angarita et al., 2018). Sinding et al’s 
(2005) paper highlighted how individuals experienced a sense of obligation to their clinicians 
counsel and how some older women had to assert their decision to decline treatment, despite 
believing that this would be in their best interest, which suggested that for some individuals 
their treatment preferences were not held as equal as their HCPs judgement, as recommended 
within a shared-decision making approach. This in turn is likely to negatively influence an 
individual’s health care experiences and their well-being and increase the risk of decisional 
conflict and the risk of decisional regret (Nicolai et al., 2016). The match between an 
individual’s preferred decision-making role and their actual decision-making role relating to 
cancer treatment is reported to be negatively associated with treatment decision regret 
(Nicolai et al., 2016) 
Perception of risk and their wish to minimise risk in relation to cancer spread, cancer 
re-occurrence, the surgical procedure and future treatments was also highlighted as 
influencing treatment decision-making. For many individual’s, cancer was associated with 
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death, uncertainty, suffering and leaving loved ones behind. An urgency to receive treatment 
was therefore evident throughout several studies as some individual’s felt required to make 
rapid decisions about treatments which had long-term and short-term consequences, despite 
HCPs encouraging individuals to carefully consider their treatment options (Morgan et al., 
2015; Pieters et al., 2012). Themes of taking responsibility were also evident as Ciambrone 
(2006) and Sinding et al. (2005) spoke of how individuals knew the course of action that they 
‘had’ to take to avoid dealing with cancer again which may not be surprising as within the 
cancer literature fear of spread and re-occurrence is not only reported to influence the 
decision-making of individuals with cancer it also influences the quality of life and wellbeing 
of cancer survivors of varying age (Chouliara et al., 2004) as well as older women’s cancer 
screening behaviour (Schonberg, Ramanan, McCarthy, & Marcantonio, 2006).  
Concerns were experienced by older women relating to their body image and changes 
to this if they were to undergo a medical intervention. Across the studies included in this 
review, concerns around an individual’s hair thinning, individuals being left with post-
operative scaring and individuals being left disfigured  were described which in turn 
influenced older women’s decision-making around whether to receive a mastectomy, 
lumpectomy, chemotherapy (Cyran, Crane, & Palmer, 2001; Husain et al., 2008; Lifford et 
al., 2015). Such fears are reported to be the same as those held by younger individuals who 
have received a diagnosis of cancer, however, studies comparing this fear between older and 
younger individuals is lacking (Angarita et al., 2018). Moreover, Cyran et al. (2001) noted 
that older women treated by female physicians were more likely than those treated by male 
physicians to raise concerns about their appearance, despite recent research suggesting that 
older women with breast cancer are keen to preserve their body image ideal, irrespective of 
age and would consider breast reconstruction surgery if this was offered to them (Fenlon et 
al., 2013). Thus, further demonstrating how an individual’s HCP, whose own judgement may 
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be influenced by ageist stereotypes around older women’s body image, can influence an older 
woman’s medical decision-making.  
The quality assessment of this review identified that many of the eligible studies 
lacked service-user involvement throughout the development of their design; only two of the 
reviewed papers demonstrated evidence of service-user involvement. Thus, highlighting a 
major limitation to seven papers, as UK policy recommends that service-users, including 
patients, carers and the public should be involved in all publicly funded health and social care 
research (Smith et al., 2008). Within the literature it is argued that including service-users in 
research processes can help achieve better quality research, which in turn may lead to better 
quality health services (Smith et al., 2008). Involving service-users as co-researchers or 
interviewers has been found to positively influence recruitment, as potential participants often 
feel less intimidated by the experience which in turn facilitates the exploration of issues and 
outcomes that are most relevant to service-users (Minogue, Boness, Brown, & Girdlestone, 
2005). The lack of service-user involvement identified throughout this review, therefore, not 
only influences the quality of research studies included in this review, it is also likely to 
negatively influence the quality of care available for older people. By not consulting with 
individuals with lived experience, many researchers are likely to have missed valuable 
opportunities for people with lived experience to share their thoughts and experiences around 
their decision-making processes, and factors which were paramount to their medical 
treatment decision-making. This in turn is likely to have prevented an in-depth exploration of 
issues and factors which are most relevant to service-users and may have resulted in 
researchers replicating the paternalistic patterns and assumptions described in the literature 
around older women’s treatment needs, their decision-making preferences and factors which 
influence their decision-making, particularly as the data collection tools utilised may not have 
explored the issues of most concern to service-users (Chouliara et al., 2004). Also, as 
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involving individuals with lived experience throughout the research process has been shown 
to positively influence recruitment and data collection, their lack of involvement throughout 
many studies may have influenced the number of participants recruited and the information 
shared by individuals, particularly if individuals recruited felt wary of the research process.  
This systematic review also highlighted significant gaps in the literature relating to 
older women’s health care decision-making. The aim of this review was to identify, appraise 
and synthesise the existing literature to better understand factors which influence older 
women’s decision-making around whether to accept or decline a medical treatment. The 
reviewers also noted the importance of exploring such phenomenon in relation to a range of 
medical treatments and in the context of varying health conditions. Despite this, only one 
paper conducted by Takase-Sanchez et al. (2015) explored decision-making outside the 
context of older women’s cancer treatment which was surprising to the reviewers, 
particularly as with increased age comes an increased risk of individuals experiencing one or 
more chronic health conditions and findings from this review highlighted how participants 
were required to consider the influence of co-morbidities alongside other factors when faced 
with a decision around whether to receive a medical treatment (Fuller et al., 2016; Office for 
National Statistics, 2018). It is thought that an increased understanding of factors which 
influence treatment decision-making for a range of health care conditions will enable 
clinicians to tailor their treatment discussions and will encourage clinicians to explore the 
needs and decision-making preferences of older women as well as the influence of factors 
outside of the condition being treated when individuals are faced with a decision around 
whether to receive a medical treatment. Thus, positively influencing the care provided by 
increasing the likelihood of person-centred discussions and care. 
 Finally, this systematic review highlighted an additional gap in the literature relating 
to the medical treatment decision-making of older women from BAME populations. Some 
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papers included within this review have made attempts to ensure that their sample was 
representative. However, only four out of nine papers slightly met this criterion and three 
papers moderately met this criterion throughout the quality assessment. Moreover, across the 
six papers which included information relating to participants’ ethnicity participants who 
self-identified as white or Caucasian represented between 61% and 100% of individuals. 
Within the literature it is well established that there are ethnic inequalities in health within the 
UK, and although historically such inequalities later in life have been relatively under 
researched, it has more recently been shown that after controlling for social and economic 
disadvantage BAME older people are still more likely than white British to report limiting 
health and poor self-rated health (Evandrou, Falkingham, Feng, & Vlachantoni, 2016). Thus, 
as an increased understanding of treatment decision-making has been shown to improve 
clinical outcomes and patient satisfaction further exploration of medical treatment decision-
making of older women from BAME backgrounds is required. Currently, it is unclear 
whether the decision-making styles and preferences as well as factors which influence the 
medical treatment decision-making of individuals from BAME backgrounds differs from 
those of individuals from white or Caucasian backgrounds. However, researchers are 
beginning to acknowledge that an individual’s cultural background may influence their 
ability or desire to engage in a shared decision-making process, particularly as certain cultural 
backgrounds lack a tradition of individuals making autonomous decisions (Elwyn et al., 
2012; Hawley & Morris, 2017) and recent literature suggests that people from BAME 
backgrounds appraise their treatment decision-making less favourably than individuals from 
white or Caucasian backgrounds (Johnson Polacek, Ramos, & Ferrer, 2007).  
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Clinical Implications 
Within the literature understanding factors which influence an individual’s medical 
treatment decision-making has increased the likelihood of person-centred care, as HCPs are 
better able to individualise treatment discussions and tailor educational strategies (Angarita et 
al., 2018). This, in turn, has been found to positively influence an individual’s understanding 
of their treatment, clinical outcomes and patient satisfaction (Angarita et al., 2018). The 
findings of this review, therefore, have significant clinical implications which could 
positively influence the care and support available to older women and in turn could enable 
older women to make more informed decisions around lifesaving and life enhancing 
treatments which fit in line with their personal values, goals and preferences.  
 In the past, clinicians may have assumed that older women could not, or perhaps 
preferred not to, be involved in decisions regarding their health care and treatment (Crooks, 
2001) when in fact the findings of this review suggest that some older women are keen to be 
involved in their treatment decision-making, are happy to be involved in treatment 
discussions and are able to draw upon various strategies to support their decision-making 
process. However, it is important to note that the degree to which older women wish to be 
involved in their treatment decision-making is variable. Thus, clinicians should not make 
blanket assumptions around their patient’s preferences and should not assume that shared 
decision-making is beneficial for all, as for some individuals imposing a choice may 
significantly increase anxiety and may lead to decisional conflict (Nicolai et al., 2016).  
 The findings of this review also demonstrate how age-related health and life 
circumstances influence older women’s decision-making. Co-morbidities, the risk of side-
effects and participants perceptions around their health, age, and strength were shown to 
influence participants decision-making. However, participants also expressed concerns 
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around how their body image, independence, caring responsibilities and quality of life would 
be affected if they were to undergo a particular treatment, which also played a significant role 
in their treatment decision-making. When supporting older women, clinicians should 
therefore ensure that time is taken to discuss and explore the influence of factors associated 
with the personal and social circumstances of the individual receiving care, as well as their 
treatment preferences and concerns. In doing this, clinicians are likely to reduce the risk of 
making paternalistic assumptions around a patient’s best interest, factors they believe do not 
apply to older women, such as body image, or those they feel are most significant to their 
treatment decision-making, which in turn will increase the likelihood of collaborative 
decision-making and person centred care.  
 
Strengths, Limitations and Recommendations for Future Research  
By identifying, appraising and synthesising the existing literature which explores 
factors that influence older women’s medical treatment decision-making this review brings 
together previously disparate research in a coherent and rigorous manner. The findings 
highlight the individuality and personal nature of older women’s medical treatment decision-
making and provides contradictory evidence against several ageist assumptions described 
within the literature including those which state that (1) older women could not or preferred 
not to make decisions regarding their care and treatment; (2)  in the context of cancer care 
women are better off to receive extensive surgery; (3) appearance and body image is 
insignificant to older women (Crooks, 2001). The review also highlights gaps within the 
literature relating to the medical treatment decision-making processes and preferences of 
older women from BAME backgrounds, individuals who have been found to appraise their 
treatment decision-making less favourably than white and Caucasian individuals (Johnson 
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Polacek et al., 2007). The reviewers therefore recommend that future research should further 
explore the treatment decision-making of individuals from BAME backgrounds to establish 
whether such decision-making differs from individuals from white or Caucasian backgrounds 
and to address both the gaps identified within the literature and the health inequalities 
experienced by individuals from BAME backgrounds. Moreover, within the context of breast 
cancer some of the fears and concerns around the impact of particular treatments described by 
older women in this review are also experienced by younger women (Angarita et al., 2018). 
However, despite this studies comparing the impact of such fear and concerns between age 
groups is lacking (Angarita et al., 2018). Thus, it is recommended that future research 
addresses this area and further compares the decision-making processes of older and younger 
women.  
 It is, however, important to note that this review is not without limitations. 
Throughout the review a second reviewer (SB) provided support throughout aspects of the 
article screening process. However, to further increase the reliability of such process the 
reviewers acknowledge that it would be preferable if the second reviewer were able to screen 
all articles identified through the systematic search. Additionally, although The QATSDD  
has previously been assessed in relation to its reliability and validity and had provided 
valuable information regarding the quality of the nine studies, the tool in fact assesses mixed 
methodological studies alongside those that only use one method of analysis which results in 
the overall quality scores of studies with a mixed methodological design being artificially 
inflated. 
Moreover, a major limitation of the review relates to the studies identified. 
Researchers were only able to access research relating primarily to older women’s cancer 
treatment decisions, which limits the conclusions that can be made in relation to older 
women’s medical treatment decision-making more generally. The reviewers therefore 
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recommend that future research should explore older women’s treatment decision-making 
within the context of varying health conditions to further understand the psychosocial 
phenomena of treatment decision-making and to increase the likelihood of person-centred 
care, particularly as co-morbidities were one of many factors described by older women as 
influencing their treatment decision-making. Although, when making such recommendation 
the reviewers acknowledge that papers, not included within this review, which explore older 
women’s decision-making in relation to mammography screening and their complementary 
and alternative medicine use, factors which influence advanced care planning and practitioner 
choices for back pain care as well as those that explore the perspectives of older women who 
did not attend screening for diabetes (Dahl et al., 2018; Kirby, Broom, Adams, Sibbritt, & 
Refshauge, 2014; Kwak & Ellis, 2019; Murthy et al., 2017; Schonberg, McCarthy, York, 
Davis, & Marcantonio, 2007; Schonberg et al., 2006) are also likely to provide important and 
clinically relevant insights into older women’s perspectives around their health, care, and 
treatment, as well as what is important for them. Future reviews should therefore not only 
explore and synthesise literature relating to older women’s decision-making in relation to 
medical treatments, as done within this review. The current literature relating to older 
women’s decision-making in other health care contexts as well as their screening behaviour 
and advanced care planning should be explored and synthesised to further understand the 
perspectives of older women and improve the health care and support available to this 
population.   
 
Conclusions  
Despite predominantly exploring older women’s medical treatment decision-making 
within the context of cancer care this systematic review highlighted the individuality and 
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personal nature of older women’s medical treatment decision-making. Contrary to previous 
assumptions, the findings suggest that many older women are keen to be involved in their 
treatment decision-making and are able to draw upon varying strategies to support such 
process. However, the degree to which an individual wishes to be involved in their treatment 
decision-making is variable and factors which influence such decision-making vary 
considerably. It is therefore recommended that clinicians do not make assumptions around 
older women’s treatment preferences and their preferred decision-making style. Instead, 
clinicians should take time to work with an individual to explore their concerns, values, social 
and personal circumstances to understand how the interplay between such factors influence 
treatment decision-making as doing this is likely to improve collaboration, encourage a more 
person-centred approach and improve patient satisfaction.  Moreover, clinicians should take 
time to provide good and accessible information around the medical treatments available to 
older women to ensure that individuals are able to provide fully informed consent as 
treatment decision-making, whether this is patient led, clinician led or shared cannot take 
place without fully informed consent.  
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A Narrative Exploration of the Decision-Making Processes of Women Aged Sixty and 
Above Who Are Offered Electroconvulsive Therapy (ECT) as a Treatment for Severe 
Depression. 
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Abstract 
 This research study explored the personal narratives of seven females who had been 
offered ECT, after they had turned sixty years of age, in order to obtain an increased 
understanding of their decision-making processes, and factors which influenced their 
decision-making around whether to receive the treatment. Data collected through individual 
interviews was analysed using Narrative Analysis and the findings were synthesised into a 
grand narrative which is presented across five chapters. The grand narrative highlighted 
several themes which influenced participants’ decision-making at the time they were offered 
ECT including, the impact of their all-consuming difficulties, desperation, being at the end of 
the road and hope. The clinical implications of the findings are discussed alongside clinical 
recommendations, including the use of thorough and robust consent procedures when 
supporting individuals who have experienced longstanding mental health difficulties. The 
study’s limitations and areas that warrant further exploration are also discussed.  
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Introduction 
 Electroconvulsive therapy (ECT); a treatment developed in the late 1930’s for mental 
health conditions such as schizophrenia and catatonia, involves passing an electrical current 
through the brain to induce seizure activity.1 Since its development, ECT has been described 
as an effective medical treatment for severe and persistent psychiatric disorders.2 The Royal 
College of Psychiatrists holds the position that ECT is a well-established and safe treatment 
option for depressed individuals who have had an inadequate response to, or tolerability of, 
anti-depressant medication3 and in the past has argued that ECT remains the most effective 
treatment for severe depressive disorder.4 It is, however, important to note that ECT remains 
controversial due to unfavourable media portrayals, its history of abuse, increased scrutiny by 
the legal system and powerful and vocal ECT activists.5 The literature surrounding ECT is 
often polarised,6 with some authors arguing that the treatment causes damage similar to a 
traumatic brain injury, significantly increases risk of death and that the cost-benefit analysis 
for ECT is so poor that its use cannot be scientifically justified.7,8 In contrast to this others 
have concluded that ECT is significantly more effective than simulated or ‘sham’ ECT, is 
probably more effective than drug therapy and remains an important treatment option for the 
management of severe depression.9 However, a more recent review exploring the quality of 
ECT versus ‘sham’ ECT trials and meta-analyses concluded that the quality of most ‘sham’ 
ECT versus ECT studies is so poor that the meta-analyses were wrong to conclude anything 
about efficacy, either during or beyond the treatment period, and argued that there is no 
evidence that ECT is effective for its target demographic or its target diagnostic group. 10 The 
authors of this review have therefore argued that ECT should be suspended immediately until 
a series of well-designed randomised, placebo-controlled studies have investigated whether 
there are any significant benefits which the proven significant risks can be weighed. 10 In the 
United Kingdom (UK) a group of professionals, individuals who have received ECT and 
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carers have also contacted the Secretary of State for Health and Social Care to request an 
urgent review into the use of ECT, a request which has been supported by MIND, a leading 
mental health charity within the UK.  
 Within the UK, The National Institute for Health and Care Excellence (NICE) 
currently considers ECT in the treatment of depressive illness, schizophrenia, catatonia and 
mania.11 In relation to depressive illness, NICE recommends that ECT should be considered 
for acute treatment of severe depression that is life-threatening and when a rapid response is 
required but should not be used routinely for people with moderate depression. Instead, NICE 
advises that in cases of moderate depression, ECT could be considered if an individual’s 
depression has not responded to multiple pharmacotherapy treatments and psychological 
treatment,12 and highlights the increased risks associated with ECT during pregnancy, in 
older people and in children so therefore, advises clinicians to exercise particular caution 
when considering ECT in these populations.11 However, it is important to note that within a 
multidisciplinary team the decision to give ECT is dependent on many different factors 
including a clinician's professional identity, how a person understands the evidence base and 
how much power such clinicians have in the decision-making process.6 This, in turn, has 
resulted in individuals experiencing differing decision-making processes around ECT 
depending on the personal views of the clinicians involved in their care.6 
 Despite NICE guidance advising that caution should be taken when considering ECT 
as a treatment for older adults, ECT is reported to be widely used in old age psychiatry 
clinical practice in Australia, The United States of America, New Zealand and the UK.13 
Also, within their writings Burstow14 and Newnes15 note that in every country where ECT is 
administered women consistently receive ECT between two and three times more than men, a 
ratio which in the past been defended by clinicians arguing that ECT is most commonly 
administered for depression and women are diagnosed with depression approximately two to 
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three times more than men.14 Such argument has been supported by historical prevalence 
figures,16,17 however, more recent research conducted in Sweden has suggested that the 
prevalence of depression is similar in men and women across all age groups.18 Also, women 
over the age of sixty are shown to account for half of the statistics in relation to the use of 
ECT, despite evidence suggesting that older women sustain the most damage from the 
treatment.15,19 
The ECT Accreditation Service (ECTAS), established to improve standards of 
practice in ECT services in England, Wales, Northern Ireland and the Republic of Ireland, 
collects data relating to the use of ECT in order to observe trends over time. Within their 
most recent minimum data set report ECTAS notes that 1114 individuals who received acute 
ECT between April 2016 and March 2017 were female, a figure which has remained constant 
since 2012.20 Also, within the same time period, 1073 out of 1821 individuals who received 
acute ECT were over the age of sixty, with the mean age being 61 years and the most 
common age being 71 years.20 Thus, although ECTAS did not specifically report data relating 
to the proportion of women over sixty to receive ECT within their 2016-2017 minimum 
dataset report, the data available suggests that women over sixty were the largest population 
to receive both acute and maintenance ECT between April 2016 and March 2017. However, 
it is important to note that the true figures relating to the use of ECT  between such time 
period are likely to be higher than those listed above as the 2016-2017 minimum dataset 
report did not include data from 46 out of 117 ECT clinics across the four countries.  
 Within the literature the use of ECT has been explored extensively; researchers have 
explored the cognitive side effects of ECT,21 the subjective experiences of older women who 
have received ECT,22 and the decisional capacity of older adults with depression to consent to 
ECT.23 Despite this, research exploring the decision-making processes experienced by 
individuals when they are faced with a decision around whether to receive ECT is sparse.24 
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Similarly, the underlying reasons behind the large difference in ECT use between men and 
women have largely been neglected.25 
‘Decision-making’ relates to the mental activities that occur when an individual is 
presented with multiple options26 and is a frequent and essential process in everyday life.24 
Within health care settings, researchers have argued that integrating evidence into care and 
engaging patients in understanding and using such evidence facilitates an individual’s 
decision-making processes and helps clients to make evidence-based decisions that are 
aligned with their treatment goals, values and personal preferences.27 Also, the guiding 
principles of the Mental Capacity Act,28 a legal framework designed to protect and empower 
people who may lack the mental capacity to make their own decisions around their care and 
treatment, note that (1) an individual should be assumed to have capacity unless it is 
established that they lack capacity; (2) a person should not be treated as unable to make a 
decision unless all practicable steps to help them to do so have been taken; (3) an individual 
should not be treated as unable to make a decision merely because they make an unwise 
decision, which in turn brings what could be understood as good clinical practice into the 
law. However, it is important to note that ECT holds a difficult position in being the only 
mental health treatment covered by both the Mental Capacity Act28 and the Mental Health 
Act.29 
 Within mental health services, shared decision-making, where an individual and their 
care team work collaboratively, share information and discuss treatment options to reach a 
joint decision about an individual’s treatment, is viewed as an ethical model of health 
communication which recognises the skills and experiences offered by all participants 
involved in making health care decisions and positively influences health outcomes.30 
However despite this, the current evidence base predominately explores decision-making and 
decision-making processes for the treatment of medical or physical health conditions; 
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literature relating to an individual’s decision-making in relation to the treatment of mental 
health conditions is lacking and therefore warrants further exploration as mental health 
conditions, along with evidence based treatments for these conditions, differ considerably to 
physical health conditions. 24 In relation to ECT, only one study conducted in The United 
States of America  has explored the experience and decision-making processes of older 
adults.24 Two studies conducted in Australia have explored the experiences of individuals’, of 
varying age,31 and the specific experiences of women25 who have received ECT in order to 
better understand what helped or hindered their decision-making process and what could be 
done to improve such process.   
Due to the disproportionate number of women over sixty receiving ECT in the United 
Kingdom and because the decision-making processes of this population are yet to be 
explored, this study aimed to gather and analyse the personal narratives of women aged sixty 
and above who have been offered ECT in order to obtain a greater understanding of their 
decision-making processes and factors which influenced their decision-making around 
whether to receive the treatment. An increased understanding of factors which influence 
medical treatment decision-making has been shown to facilitate more personalised treatment 
discussions between health care professionals and service-users, reduces the risk of 
misinformation and can enable clinicians to tailor educational strategies which in physical 
health settings has improved patient satisfaction and clinical outcomes.32 From an economic 
perspective shared-decision making has also been associated with reduced hospitalisation and 
increased adherence to medication which may in turn positively influence care costs. 27,30 It is 
therefore thought that the findings from this study will help support the planning of future 
clinical practice and improve the support available to older women, when they are faced with 
a decision around whether to receive ECT as in the past the strong and often polarised views 
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around ECT are likely to inhibit open discussions around the treatment, which in turn may 
influence an individual’s ability to make the best-informed treatment decisions.31  
 
Method  
 Throughout this study a qualitative design which adopted a narrative approach was 
utilised to explore the experiences of women who had been offered ECT after they had turned 
sixty years of age. Such approach was considered to be the most appropriate approach to 
achieve the study’s aims as it allows an in-depth exploration of an individual’s experiences 
and enabled the researcher to explore each participant’s personal narrative, as influenced by 
any personal, ethical, social or political issues that the research may bring.33 
 
Participant Characteristics 
 Women, who were residing in England and had made a decision around whether to 
receive ECT as a treatment for severe depression since becoming sixty years of age, 
irrespective of whether they opted to receive or decline the treatment, were invited to 
participate in this research project. In total seven individuals, all of whom had opted to 
receive ECT since becoming sixty years of age, participated in this study. Further information 
relating to participant characteristics and their demographics were not collected throughout 
this study in order to further protect participant anonymity. It was felt that this was 
particularly important as participants were predominantly recruited from one NHS 
Foundation Trust.  
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Procedure 
 The study was advertised across multiple sites within one NHS Foundation Trust in 
the North West of England, as well as via third sector organisations and social media. 
Clinical staff, who worked across the NHS recruitment Trust, approached individuals who 
met the study’s inclusion criteria and provided them with information about the study and 
also advised whether it would be appropriate for the researcher to contact potential 
participants. Depending on the potential participants preference, individuals were then either 
encouraged to contact the researcher if they wished to participate or, with permission, their 
contact details were shared with the researcher in order to allow the researcher to provide 
more information about the study. 
 
Table 1. Potential Participants Identified from the NHS Recruitment Trust  
Potential Participants Identified N 
Individuals identified from the NHS recruitment Trust who met the research 
study’s inclusion criteria 
43 
Individuals who were contacted in relation to the research by either clinicians 
working within the NHS recruitment Trust or the researcher 
18 
Individuals who, when contacted, advised that they did not wish to participate in 
the research 
12 
Individuals who, when contacted, were interested in participating in the research 6 
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 Table 1 highlights the proportion of potential participants identified from the NHS 
recruitment Trust and those contacted in relation to the study by either the researcher or 
clinicians working within the NHS recruitment Trust. Not all potential participants identified 
from the NHS recruitment Trust were contacted, because for some the lead clinician involved 
in their care felt participating in research would be too demanding due to their current 
physical, psychological or personal circumstances. Of the eighteen potential participants 
contacted, twelve were not interested in participating in the research and provided reasons for 
this. Such reasons included personal circumstances such as the individual experiencing 
difficulties with their mood or them having caring responsibilities. Whereas, other individuals 
explained that they “could not really remember anything” from that time in their life, had 
“found ECT frightening” and did not wish to speak more about their experiences, and 
believed they “didn’t really have a choice” so felt they couldn’t comment on decision-
making.  
 The six potential participants who, when approached, advised that they were 
interested in participating in the research either contacted the researcher by telephone or 
email or, if the researcher was advised by the potential participant’s clinician, were contacted 
by the researcher in order to confirm eligibility, to establish the best way for the researcher to 
provide potential participants with the study’s participant information sheet (Appendix C) 
and to answer any questions relating to the research.  
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Table 2. Potential Participants who Contacted the Researcher Directly  
Potential Participants who Contacted the Researcher Directly N 
Individuals who also contacted the researcher in relation to the study 6 
Individuals who were ineligible to participate in the research 5 
Individuals who were eligible to participate in the research 1 
 
 Also, in addition to the potential participants identified through the NHS recruitment 
Trust, six individuals, who had seen the study advertised via social media and through third 
sector organisations, contacted the researcher directly, either by telephone or email, to discuss 
their interest in the study. Following a telephone call with each of these individuals, the 
researcher confirmed that five individuals were ineligible to take part but thanked them for 
their interest. One individual who contacted the researcher directly was eligible to participate, 
in line with the study’s inclusion criteria. Table 2 highlights the proportion of people who 
contacted the researcher directly to discuss their interest in the study.  
 In total, seven research interviews were arranged and were conducted in person. The 
researcher travelled either to the participant’s home or a place of their choice which would 
maintain their security and confidentiality. Before conducting each interview, the researcher 
obtained written informed consent from each participant, through using the study’s consent 
form (Appendix D). Also, throughout each interview the researcher utilised an interview 
guide (Appendix E) which began with an open question in order to increase the likelihood of 
participants describing their experiences and sharing their personal narrative. However, 
clarifying questions and additional prompts were also used throughout the interview to 
encourage expansion. When considering the target population for this research, the 
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researchers believed that the use of clarifying questions and additional prompts within each 
research interview would be particularly important as cognitive impairment, in the form of 
persistent and significant memory dysfunction, has been shown to be related to ECT.8 All 
interviews were audio recorded and later transcribed verbatim. 
 Following the research interview, participants were provided with a debrief form 
(Appendix F) and an opportunity to ask questions about the research. A summary letter, 
which aimed to capture the key events, experiences, people and  places detailed within 
participants’ personal narrative as well as their significance to the participant at the time they 
were offered ECT, was also sent to six out of seven participants following their research 
interview in order to increase the trustworthiness of the data. Unfortunately, it was not 
possible to share a written summary letter with one participant as she was experiencing 
difficulties with her physical health. All six participants, who received a summary letter 
provided feedback in relation to this, either by letter, email or telephone. Within their 
feedback, most participants advised that the summary letters captured their experiences well. 
Several individuals also recalled further detail around their experiences and concerns at the 
time they were offered ECT, as well their experience of other treatments for depression. This 
information was used by the researcher, alongside participant’s transcripts and their summary 
letters, to support the data analysis process and to support the development of the grand 
narrative.  
 
Reflexivity Statement  
 All qualitative research is contextual and occurs within a particular time and place 
between two or more people.34 The actions of the researcher or those hearing an individual’s 
narrative are, therefore, argued to be as central to the narrative as the narrator themselves, as 
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the researcher is considered to be a co-creator of meaning.35 With this in mind, it is important 
for narrative researchers to consider their personal, professional and epistemological 
positioning and the impact that this may have on the research. When completing this 
research, the primary researcher, and the individual completing each research interview was 
employed by the National Health Service (NHS) as a Trainee Clinical Psychologist. Such 
positioning in the NHS may have influenced the narratives described by participants. Also, in 
the past, the primary researcher had also volunteered in a country whose cultural 
understanding of mental health and distress was significantly different to her own. Whilst in 
such country the researcher observed the frequent use of ECT and was provided with an 
opportunity to observe the treatment. This experience had resulted in the researcher holding a 
negative view of ECT, a view which had been perpetuated as the researcher had been 
exposed to highly critical narratives around the use of ECT throughout her career and 
professional training in clinical psychology, and this in turn increased the risk of bias. 
To reduce the risk of bias several steps were taken by the researcher, in line with 
credibility guidelines developed for qualitative research studies in psychology and other 
related fields.36 Such steps included (1) the researcher being aware of her own perspective 
and how this may influence her interpretation of the research data; (2) the researcher using 
participant quotes throughout the results section in order to highlight specific examples of 
each theme; (3) the researcher using several methods to in order to check the credibility of the 
themes identified, such as the researcher obtaining feedback from participants in relation to 
their individual summary letters, and the researcher discussing such themes during frequent 
meetings with her research supervisors, one of whom met the inclusion criteria for this 
research project; (4) the researcher presenting the key themes identified within the data across 
several chapters to ensure that the research findings are presented in a concise and coherent 
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manner. To increase the researcher’s awareness of her own perspective and how this may 
influence her interpretation of the research data a reflective diary was used.  
 
Service User Consultation 
Throughout this research, one of the three research supervisors was a woman who had 
been offered ECT after she had turned 60 years of age and therefore met the study’s inclusion 
criteria. This shaped the research in a range of ways as the researcher was able to gain a 
greater understanding of the experiences of someone who had lived experience of the 
phenomena of interest. Along with their supervisors, the researcher was therefore able to 
adapt the interview guide utilised throughout the research interview to ensure that they 
adequately explored areas and factors which held significance to the individual with lived 
experience. The researcher also adapted the recruitment poster used throughout the study 
(Appendix I) to ensure that this caught the attention of potential participants, whilst reducing 
the risk of the content being intimidating for viewers, after considering the individual with 
lived experience’s feedback. Additionally, the supervisor with lived experience was involved 
with a range of service user and survivor networks and generously made links with these 
networks to advertise the study which, in turn facilitated the recruitment process. Moreover, 
as described in the reflexivity statement, the researcher attended frequent meetings with all of 
their research supervisors, including the individual who had lived experience of the topic of 
interest. During these meetings the researcher frequently discussed the themes identified 
throughout the data analysis process in order to reduce the risk of bias and to check the 
credibility of their research findings.   
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Ethical Considerations 
 Ethical approval for this study was granted by an NHS Research Ethics Committee in 
the North West of England, the Health Research Authority (HRA) in England and Health and 
Care Research Wales (HCRW) in September 2019. Evidence of this approval can be found in 
Appendix G. Prior to taking part, all participants were provided with the study’s information 
sheet (Appendix C) which highlighted the aims of the study, what taking part would involve, 
how participant data would be used and stored, any risks associated with taking part 
including, the risk of emotional distress and the risk of participant’s narratives being 
identified as direct quotes would be used within the write up and, the participants right to 
withdraw from the study. To maintain participant anonymity, all identifying information was 
removed at the point of transcription and all participants were provided with pseudonyms.  
Upon reading the participant information sheet, all participants provided written informed 
consent. Also, due to the risk of participants experiencing emotional distress through their 
participation in this research, the researcher followed a distress protocol (Appendix H) 
throughout participant interviews. This highlighted an appropriate course of action for the 
researcher to take, should a participant experience distress through their involvement in this 
study.  
 
Data Analysis  
 To obtain a rich understanding of participant experiences and other factors which 
influenced the decision-making processes experienced by individuals at the time participants 
were offered ECT a narrative approach to analysis was utilised by the researcher. Narrative 
analysis (NA), a qualitative approach dependent on the ideas developed in narrative 
psychology, refers to many different styles of work.37 There is, therefore, no one way to 
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conduct NA or no definitive framework to follow35,38 However, ultimately the methodology 
relates to the exploration of a person’s own narrative as influenced by any personal, cultural, 
ethical, social or political issues that the research can bring.33  
 This research was guided by several narrative methods and frameworks including 
those described by Crossley38, Reissman35 and Weatherhead.33 Initially each interview was 
listened to and transcribed verbatim. The transcript was then read several times to familiarise 
the researcher with the data.38 Once familiarised, the researcher then explored each transcript; 
Narrative tone, characters and key themes were noted38 as well as the order in which 
participants discussed and described each of the key themes in order to explore both the 
structure and the content of participant’s personal narratives. NVivo 12 software was utilised 
by the researcher to support this process. Summary letters were then written for each 
participant in order to highlight key events, experiences, people, places and their significance 
to the participant at the time they were offered ECT. Participants provided feedback on these 
summary letters, any requested changes or additional reflections, were included in the final 
version of these letters to ensure the analysis captured their experiences and the significance 
of these.   
 Once participants had provided feedback on the summary letters, the researcher 
examined each transcript for shared themes, characters, experiences and narratives. 
Commonalities across the transcripts were amalgamated and synthesised to develop a grand 
narrative or what Howitt describes as a coherent story,37 which was described by participants 
across the seven interviews. This approach has the potential to shift away from the larger 
pedagogic and emancipatory aims of qualitative research, if not done sensitively39. However, 
as there were many similarities across participant narratives it was felt that a grand narrative 
approach would enable the researcher to present the extensive data gathered through 
individual interviews in a concise and coherent manner. To reduce the risk of losing the 
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uniqueness of each participant’s narratives and key elements of their experience the grand 
narrative developed was compared against each participant’s summary letter and their 
feedback. Also, to further increase the trustworthiness, reflexivity and rigour in the analytical 
process, supervisors remained involved in the analytic process and provided feedback on 
participant summary letters and throughout the development of the grand narrative. The 
researcher also maintained a full paper trail and compared coding with her research 
supervisors to further increase the rigour of the study.40 
 
Findings 
 The findings outlined below represent the grand narrative which emerged through the 
seven interviews, the participant summary letters, and the feedback provided by participants. 
The grand narrative is organised into five chapters with chapters one and two exploring the 
difficulties experienced by participants prior to them being offered ECT and the alternative 
treatments tried. Chapters three and four explore participants thoughts and feelings when they 
were offered ECT as well as their experiences when they received the treatment. Finally, 
chapter five describes participants reflections after receiving the treatment.  
 
Chapter One- Difficulties experienced prior to being offered ECT, “people say it’s a black 
hole and it really was black” 
 Within this chapter, the difficulties experienced by participants prior to being offered 
ECT were explored. Across the seven narratives, participants described themselves as 
experiencing longstanding or chronic difficulties with depression prior to them being offered 
ECT, which for some individuals “peaked and troughed, but didn’t really go away 
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completely” (June) and had left individuals feeling “really poorly” (Kay) and “absolutely 
dreadful in myself” (Tania). One participant described herself as “going around seriously ill 
for two years” (Nancy). Participants used imagery and metaphors and described their 
experience of depression as being like “a big black hole” (Nancy) and “looking through the 
world through dark glasses” (June). Whereas, others described how their experiences had 
impacted their life. Tania described that time in her life as a “dreadful, dreadful time” and 
explained “my life wasn’t functioning right at all, no interests, couldn’t do anything”. 
Similarly, when speaking of her experience of depression Ruth said “It’s a weird thing, that 
you just can’t… you can’t visualise getting through a day, you can’t be bothered with 
anything, you don’t want to eat, you just wander around the village, just wander aimlessly 
around [like a] lost soul”.  
 As participants described the impact of their difficulties on themselves and others, 
themes of loss and burden became evident across the narratives as “the world is just not the 
same place. It’s a horrible [place]” (June) and others were “bearing the brunt of it” 
(Kathryn).  
“It affected all sorts of things, you know, family, friendships. I suppose I felt worthless and I 
didn’t want to make other people depressed either, so I felt I didn’t want to speak to other 
people or see them. I wasn’t very good company, so I didn’t want to inflict it on anyone else” 
(Kay).   
Participants held different understandings of factors which had influenced their 
difficulties. Across the seven narratives participants described the potential influence of 
circumstantial factors. 
“I know I’m usually in pain, that’s usually the start of it and I start getting a lot of 
nightmares at night and they’re very bloody in their [nature]” (Celia).  
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However, the notion of chemicals in the brain and genetic factors contributing to participants’ 
difficulties were also evident within participants’ understanding of their difficulties. 
“But in your brain, it’s a chemical imbalance. It’s the clinical depression or a circumstantial 
depression. They said mine was clinical, people [and] circumstances hadn’t changed” 
“Other people get the circumstantial depression, bereavement or loneliness, but mine wasn’t 
like that” (June). 
“See I don’t know whether it is hereditary, depression, because my father suffered from 
depression lots and I don’t know whether that came down to me or it was totally different 
circumstances that gave me depression. I’ve no idea” (Kathryn).  
 
Chapter Two- Experience of other treatments, “Before you know where you are, you’re 
taking a cocktail full of stuff” 
Throughout their narratives, participants spoke of their experience of mental health 
treatments prior to them being offered ECT and several individuals understood or believed 
that ECT was not offered as a first response “It’s down the line, if you know what I mean. If 
things aren’t progressing or working” (June). Tania explained that “you have to wait for the 
right time to be offered it”. However, Celia spoke with frustration around her consultant’s 
willingness to offer ECT and believed that because her consultant leaves ECT as a last resort, 
it has in the past resulted in her requiring a more intensive course of treatment. Celia 
explained that her consultant “does not listen to the wishes of his patient”.  
Consistently across the narratives, participants described their experience of 
pharmacotherapy and explained that either their psychiatrist or general practitioner (GP) 
“had tried all sorts of different medications and combinations of medications, but nothing 
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seemed to help” (Kay). Ruth spoke with frustration and concern when she said “I mean I’d 
been on so many drugs. I’ve got stuff to make me go to sleep, and they’re not working. The 
sleeping tablets didn’t work at all. I still wasn’t sleeping, up and down all night long and 
these antidepressants… They certainly weren’t anti-depressing me, I was just as bad as ever. 
Then I was putting all these things down my neck and I was well aware [of] what I was 
putting down my neck”. Also, participants  spoke of their medication being changed which 
“meant kind of starting again from scratch, getting those funny feelings in your head that you 
can get until your body gets used to them” (June) and going through “this wean off period, a 
start-up period [whilst] all the time you’re full of hope.” (Ruth). 
Participants described varying experiences of psychiatric support, with some 
individuals describing positive experiences, “It helped so much that people were listening to 
me. See before, people weren’t listening to what I was saying. Know what I mean?” (Nancy). 
Whereas, others described having time limited appointments with their psychiatrist, an 
individual that would change frequently from appointment to appointment. June, in 
particular, spoke with disappointment about her clinician frequently changing and explained 
that the psychiatrist “didn’t even know you as a person. It’s such a personal illness really, 
you know” and wondered whether there was a shortage of psychiatrists or her experience was 
influenced by the way the government funded mental health services. 
 In addition to psychiatric support, participants described varying experiences of other 
mental health treatments prior to being offered ECT. Three individuals explained that they 
had not been offered any other treatments, such as psychological therapy prior to being 
offered ECT. Kathryn explained “there’s not anything particular that I do or feel that I feel 
talking therapies would get me over.” Whereas, Nancy and Kay had both engaged in 
psychological therapies after receiving ECT and Kay had wondered “Maybe if I’d had more 
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help-talking therapies, years ago, but it wasn’t nearly as common then, that would have 
helped, and maybe I wouldn’t have needed ECT. But it just wasn’t around”.  
 In contrast, all other participants described engaging in a range of therapeutic 
interventions prior to being offered ECT, including group interventions and one to one 
therapy. Since her 40’s Tania, explained that she had seen a range of professionals and when 
discussing this reflected “Did I see those many people? Yes, yes I did because somehow I 
couldn’t get out of this place”. Similarly, Celia explained that in the past she had “done so 
many different therapies” and Ruth advised that she had attended psychological therapies, 
had paid privately to receive ECT and Transcranial Magnetic Stimulation (TMS) and had 
engaged in hypnotherapy, she said that “this whole thing cost me a fortune”.  
 
Chapter Three- Thoughts and feelings when offered ECT, “If I don’t do this, I’m at the end of 
the road” 
 Within this chapter, participants described their experiences at the time that they were 
offered ECT, factors which had influenced these thoughts and feelings, people who were 
available to provide them with support and what it was like for them to make a decision 
around whether to receive ECT. Common themes across participant narratives included 
feelings of desperation and being at the end of the road, not knowing what to do, taking 
responsibility, hope and trust. June described how she felt towards the depression and 
explained “I just wanted it to kind of stop, you know, to be finished and feeling well”. 
However, participants reported mixed feelings when they were initially offered the treatment. 
Kathryn explained “I was going to have it before I had it and I said that they would fry my 
brains and I wouldn’t have it. Similarly, Kay described initial feelings of reluctance but 
explained “although I had said I wouldn’t have ECT again, it got to the point, you know, I 
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was quite desperate really to have some help because the medication just wasn’t doing 
anything”. Kay also noted “when the subject of ECT came up-I was reluctant, but I thought 
that was all there was left to do; and you get to the point when you feel that staff will give up 
on you if you don’t anyway. So, it seemed the option really”. Whereas, Tania felt glad to be 
offered ECT but “hoped that erm which sounds awful, but I hoped that I would die on the bed 
and then it would have been taken out of any-body’s hands” 
 Participants described being encouraged to speak to family members and friends at 
the point they were offered ECT. Nancy recalled that the psychiatrist supporting her had said 
“what we’re going to have to do, you’re so badly depressed and all that happened we think 
we’ve got to give you ECT. So, have a word with your family, or they can come and see us, 
you know, and they can see what’s going on, or we’ll explain everything. It was all very 
good”. Overall, participants spoke positively about the support provided by family members 
throughout the decision-making process and many recalled their family members being ‘for 
ECT’ or encouraging them to receive the treatment “Oh, they were all very supportive. Yes, 
and it was my decision, ultimately, but they all… there was my two children and my husband. 
Yes, they were wanting to support me. It did seem the best thing to do” (Kay).  
Moreover, several participants described how they trusted and valued their husband’s opinion 
so were appreciative of their husband’s support throughout the decision-making process 
“I sort of trust [Husband’s name]’s judgement. I always have because he’s not a panicker, 
he’s level-headed, sort of thing. So, I thought he’s going to be supportive and if he thinks it’s 
going to help. He’ll be with me… He’ll stand by me” (June).  
However, some participants described differing views across family members and friends 
who have supported them in the past. Celia, in particular, explained that her sibling had been 
against her receiving ECT in the past and described how she had managed this more recently. 
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“My family don’t know that I go for it [ECT] now, because they thought it was too 
degrading, me being in hospital and the forgetfulness. So they don’t know the last twice I’ve 
had the outpatient one [course of ECT]. It’s only my friend and my partner that knows” 
 Participants had varying knowledge of ECT at the point they were most recently 
offered the treatment and one strategy used by some individuals was to draw upon their 
previous experiences. Kay explained that she had first received ECT when she was coming 
up for thirty “I was an inpatient then, which was quite different anyway, and the way people 
were treated was very bad actually. No compassion, it seemed to me. Just treated like cattle, 
yes. And coming around afterwards, you feel really groggy and not really any support 
around, as I recall”. Whereas, Nancy recalled the conversations she had held with other 
people and the information she had seen in the media around ECT “People were so against 
[ECT] at the time, do you know what I mean? It was in the papers and everything, you know 
what I mean. Said you shouldn’t treat people…[in that way]” . She explained that this 
knowledge had increased her feelings of anxiety prior to her receiving her first few 
treatments.  
 Participants also described receiving varying information around ECT, from the 
psychiatrist who had offered them the treatment and the service supporting them with some 
individuals being advised of both the benefits and risks associated with the treatment and 
others being advised that ECT would only affect an individual’s memory on a short-term 
basis.  
“I don’t remember anyone talking to me about the good things about ECT, alright, but I do 
remember them saying it would only affect your memory when you have it, short term. Yes, 
like not remembering what was happening over the treatment”. (Kathryn) 
80 
Older Women’s Decision Making in the Context of Medical Treatments 
 
 
 
Kay described receiving written information around ECT and explained “we were able to go 
home and talk about it as a family, read about it, and discuss it, and come to a decision. So, it 
was completely different [than the first time]”.  
 Kay described what it was like for her to weigh up her experiences, the information 
provided and what she knew of ECT.  
 “There was quite a lot of negativity about it; some staff didn’t want to take part in this 
treatment and didn’t agree with it at all. So, it’s a lot to take on board and to mull over when 
you know some staff don’t want to do it. I don’t know now how much controversy there is 
about ECT nowadays. I know they don’t offer it nearly as often. Well I know I read at the 
time, earlier on. I’ve read that people had different views about it, and if the staff can’t agree, 
you think… “How can you know really?” But as I’ve said, I was desperate really. So, that 
was the decision I made” 
In contrast to this, Ruth advised that her decision to receive ECT “didn’t take much 
deciding” despite knowing that it is such an extreme treatment. Ruth reported that at that time 
in her life she was in such a state and “just wanted that feeling of being at peace with myself 
and what I was doing”. She explained that “nothing else had worked and at least after trying 
ECT, I knew[that] I had tried everything”. A sense of taking responsibility for one’s own 
health was also evident throughout Tania’s narrative, who when faced with the decision had 
thought “I don’t know anything else. You know to not try it, at least if I’ve tried it erm.. I kind 
of can see if it helps me”. However, June described how throughout this process she had 
leaned on her husband and thought “I don’t know if I’d have done it without [husband] quite 
honestly, or I would have been more nervous anyway.” She explained “he was very good. I 
felt [through trying ECT] there was hope for both of us really. I knew [husband’s name] 
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would be there for me because he’s the kind of person who would be there for people as it’s 
his nature.” 
 
Chapter Four- Experiences when receiving ECT, “the staff really were marvellous and had 
made me feel safe” 
 Throughout their narratives, participants discussed their experiences when receiving 
ECT and spoke about the support they received from clinicians, their thoughts and feelings 
when they received the treatment and how they experienced ECT. Participants described 
initial feelings of nervousness and anxiety prior to receiving the treatment  
“I had to be wheeled down and go into this room and you had to have things on your head 
so…until you went out it was done… right up until the last minutes you’re awake. Do you 
know what I mean? I think that made me more nervous than anything. Know what I mean?” 
(Nancy) 
However, participants described the support provided by clinicians as helpful and reassuring. 
“they [the ECT clinicians] were nice and they explained everything they were doing, and they 
sort of put the needle in and the nurse was holding my hand and it does make a difference. It 
really makes a difference. I didn’t feel I had to put on a show, that erm I’m tough. I said this 
is how I feel, how I truly feel and I’m desperate. And umm it takes a lot to say that, you know. 
But it’s best to” (Tania).  
Kay compared her most recent experience of ECT, to when she had first received the 
treatment and explained “it was a completely different experience. I mean it’s not pleasant 
but it’s much better; everyone was treated individually and helped and supported. So, it was 
very different” 
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 Participants described how they had found ECT and whether this had influenced their 
mood. All but one participant described ECT as helpful. Nancy explained that “it lifts your 
mood, slowly, but very surely. You know what I mean. It wasn’t an overnight success. It was 
very, very slow”. Similarly, Celia explained that after receiving ECT “I start to plan more 
positively and think of the future”. She also noted that the nightmares she experiences start to 
reduce and “I can put the suicidal thoughts into a box, rather than have them in my head all 
the time”. However, in contrast to this June had declined her final scheduled ECT treatment.  
“ I had 16, well they booked 16 in, which actually is quite a lot. I can remember being upset 
and they said you’d only got one more to go and I said I’ve had enough; I’m not having 
anymore. I can remember feeling down because I don’t think I did feel any better…I just 
remember being upset. I just felt like I’d had enough, tired of it, going every week.” 
June also described feeling under pressure and out of control at the time she declined her final 
ECT treatment. 
“I can remember them saying oh come on, you’ll have to have the…this could be the 
one….and [my husband] was saying this could be the one that’s a turning point. Why come 
this far and not have the last one? And the psychiatrists saying…the more they went on, the 
more I went against it. So I didn’t have the last one because I don’t think out of 16 one would 
have made a difference.” “It was like bullying in a way, not bullying. I felt like it was a 
pressure and I didn’t want it and I sort of dug my heels in I think.” “ I just felt I’d had 
enough. I was scared to be honest. If I’m truthful. I felt frightened of what was happening to 
me. And the feeling of being out of control is horrible as if you can’t control, they’d be 
controlling me and this thing was controlling me to a certain degree.” 
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Chapter 5- Experiences and reflections following ECT, “I’m on the road to recovery here, 
through my own perseverance” 
 Throughout their narratives, participants shared their experiences, as well as their 
thoughts and feelings around ECT after receiving the treatment. Participants also reflected on 
their experience of mental health care. Consistent across several narratives was the 
experience of memory difficulties following ECT. Celia explained that she experienced 
significant memory difficulties  “for the time before I start it [ECT], as well as about 6 
months after” and explained that “it’s the price you pay for it, really and that’s the only price 
I pay for it, is the memory [difficulties].” Similarly, Tania explained that following ECT she 
believed that her memory had worsened. However, she thought it was “best to have lost a bit 
of memory and be here to see friends, family”. In contrast, Kathryn described experiencing 
much more significant memory impairments following ECT, which were highlighted 
throughout the interview. Kathryn explained “It’s the funny things that have gone, you know, 
things I should remember but I don’t remember. Erm, I just put up with it now. However, 
Kathryn described this as “not as natural” and a problem, particularly due to her family 
circumstances. 
 When sharing their thoughts on ECT after receiving the treatment, participants 
described different views. June said disappointedly “I thought it [ECT] was going to make me 
better, but then it just wasn’t. I wouldn’t want it again, put it that way. It’s not because of 
anything painful, because you’re asleep. I don’t really like hospitals to be truthful. I don’t 
like being away from home, unless I’m going somewhere I want to go” and wondered about 
the long-term consequences of receiving ECT. However, Tania believed that ECT had been 
helpful to her and explained “If anybody ever asked me what I knew [about ECT], what I 
think about it, I would say well if you’re really at what I call the end of the road and you’re 
going to tip away then erm… I would say give it a try”. When she opted to receive ECT, 
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Tania described herself as “definitely, at the end of the road”. Moreover, Ruth described 
herself as “on the road to recovery here through my own perseverance” following ECT. 
However, she explained that she was cross about the psychiatric care that she had received as 
her community psychiatrist “could not make a decision around ECT” and whilst staying in 
an informal inpatient facility a psychiatrist had informed her that she “did not have 
depression” so therefore would not be considered for ECT. Ruth reported that she had paid a 
considerable sum of money to receive ECT on a private basis, something she was entitled to 
on the NHS, and therefore described feeling let down and annoyed as “I’ve, had no kids, no 
maternity benefit” and had had a very long working career. 
 Two participants reflected on their experience of trying different treatments prior to 
ECT. Kay wondered “Maybe if I’d had more help, talking therapies, years ago, but it wasn’t 
nearly as common then, that would have helped, and maybe I wouldn’t have needed ECT. But 
it just wasn’t around”. Whereas, Celia believed “they delay giving me the ECT, [when] I 
would have benefitted from it earlier” and noted “If only I’d had the opportunity to have it 
earlier, then I think 6 to 8 sessions may well have been enough and I think the memory loss 
and that wouldn’t have been as bad….That’s only because I know me, do you know what I 
mean? And I know what’s worked in the past I think”. Finally, Kay reflected on the 
information she had received around ECT, the second time she had received the treatment 
and although she was grateful to receive this “it would have been much nicer to be able to 
talk to someone who had had the treatment, or someone else, a member of staff telling you a 
bit more about it, rather than the consultant who was saying “would you like to have this or 
not?”. To talk to someone a bit more about it and the actual physical sort of way it worked”. 
Overall, Kay reported that her most recent experience of ECT “was so much better than the 
previous occasion, so I didn’t think too much about it. But latterly, I think it could have been 
much better, with hindsight”.  
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Discussion  
 This research explored the personal narratives of seven women who were offered 
ECT after they had turned sixty years of age, in order to obtain a greater understanding of 
their decision-making process and factors which influenced their decision to receive the 
treatment. Prior to this investigation, the evidence base predominantly explored decision-
making and decision-making processes in the context of medical or physical health 
conditions.24 Literature relating to an individual’s decision-making in relation to the treatment 
of mental health conditions, and research specifically exploring the decision-making 
processes experienced by individuals when they are offered ECT, was sparse and therefore 
warranted further exploration as mental health conditions, along with evidence based 
treatments for these conditions, differ considerably to physical health conditions.24  
 A range of commonalities were identified throughout the seven participants’ 
narratives. These were therefore amalgamated to develop a grand narrative which consists of 
five distinct chapters and details the difficulties experienced by participants prior to them 
being offered ECT, their experience of other treatments, participant’s thoughts and feelings at 
the time they were offered ECT, their experiences when receiving the treatment and their 
reflections. The grand narrative also demonstrates the range of factors which influence older 
women’s decision-making around ECT; including their experience of different mental health 
treatments, personal knowledge and experience of ECT, information provided by clinicians, 
perspectives of family and friends, and the quality of older women’s relationships with those 
individuals. However, the impact of their difficulties with depression alongside feelings of 
desperation and their desire to “get rid” of distress, appeared to be the most influential. This 
was emphasised by several themes including a sense of being at the end of the road and 
participants taking responsibility for their health and well-being. The decision-making 
processes experienced by older women when faced with a decision around whether to receive 
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ECT is highly individualised and personal. However, further information regarding this 
process, as well as factors which influenced participants decision-making is outlined within 
Figure 1. 
 
Figure 1: A model highlighting the decision-making processes experienced by participants 
when faced with a decision around whether to receive ECT, adapted from the model 
developed by Angarita and colleagues.32 
 
 Prior to being offered ECT participants described themselves as experiencing 
longstanding and all-consuming difficulties with depression and had used powerful imagery 
and metaphors to describe how such difficulties were like being in a “big black hole”. 
Participants also described how their difficulties had impacted both themselves and others, as 
at that time in their lives participants interests and functioning were significantly affected 
which, in turn, resulted in participants relying on others for support and loved ones “bearing 
the brunt” of participant difficulties or being required to make “sacrifices”. Thus, highlighting 
themes of loss and burden. Moreover, participants spoke of varying experiences of mental 
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health treatments prior to them being offered ECT with participants consistently describing 
their experience of pharmacology but describing varying experiences of psychiatric care, 
psychological therapy and accessibility to such support. One participant in particular 
described herself as frustrated and cross about the mental health care she had received and 
had in fact paid privately to receive ECT, TMS and hypnotherapy, which had significant 
financial implications. Also, across several of their narrative’s participants spoke of how they 
were required to hold onto hope whilst trying different medications and trying to ‘get rid of 
their depression’. 
 In line with NICE guidance, which advises that ECT should not be used routinely for 
people with moderate depression and instead clinicians should consider the treatment if an 
individual’s depression had not responded to multiple drug or psychological treatments,12 
several participants understood that ECT was not offered as a first response and that 
individuals “have to wait for the right time to be offered it”. Two participants spoke with 
frustration in relation to their clinician’s willingness to offer the treatment. One individual 
believed that in the past she has required a more intensive course of ECT because her 
consultant leaves this as a last resort and the other individual described herself as having to 
fight for her health and well-being because her clinician could not make a decision around the 
ECT. These experiences provide support for the findings made by Duxbury and colleagues6 
who noted that individuals are likely to experience differing decision-making processes 
around ECT, depending on the personal perspectives of clinicians involved in their care and 
the power such individuals hold within an MDT. However, despite such experiences, the 
paternalistic view of the ‘doctor knows best’ was present throughout several participants  
narratives as individuals described how they cannot argue with professionals and how the 
professionals “know what they are talking about”, views which have been linked to 
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individuals engaging in clinician-driven decision-making styles and individuals taking a more 
passive role in their treatment decision making.41  
  Common themes across participant narratives when they described their experiences 
at the point they were offered ECT included feelings of desperation, being at the end of the 
road, not knowing what to do, taking responsibility hope and trust. Participants spoke of their 
desire to get rid of the depression and to be feeling well again. However, they reported mixed 
feelings when they were initially offered ECT, with some individuals feeling reluctant and 
others feeling glad. Participants recalled being encouraged to speak to their family and 
friends about their treatment options and many individuals spoke positively of the support 
and advice provided by their family and friends. In particular, several individuals spoke of 
how they had trusted their husband’s judgement and associated this trust with aspects of their 
husband’s personality, the quality of their relationship with their husband and how well they 
perceived their husband to know them. They, therefore valued their thoughts around ECT, 
which in turn influenced their decision-making. Moreover, throughout the decision-making 
process additional strategies used by individuals included drawing upon their previous 
experiences of ECT, considering the conversations they had held with others and recalling 
discussions held in the media around ECT, which for some increased feelings of reluctance 
and anxiety, and considering the verbal or written information their psychiatrist had provided 
them with around ECT. However, participants described themselves as receiving varying 
information around the treatment with some individuals. Several individuals noted that such 
information had highlighted the benefits and risks associated with ECT, with the risks 
highlighting the potential of memory difficulties following ECT. Whereas, one individual 
could not recall being informed of the benefits to ECT and was told that ECT would only 
cause short-term memory difficulties, when in fact the memory difficulties she had 
experienced were much greater than this, which in turn raises ethical concerns as it is likely 
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that some participants were not provided with sufficient information around ECT, as well as 
the risks associated with the treatment, to provide fully informed consent.   
 With regards to decision-making, two participants described what it was like to weigh 
up their experiences, the information provided and what they knew of ECT. One participant 
described the amount she had to consider, whereas the other individual described the decision 
as “not taking much deciding”. Nonetheless, both individuals explained that their feelings of 
desperation had, ultimately, influenced their decision and consistently participants described 
a sense of responsibility to try ECT as they didn’t know what else to do and had hoped that 
ECT “would work” both for themselves and their loved ones, factors which have been 
considered to influence an individual’s ability to provide informed consent. Within their 
paper Clarke and colleagues25 note that coercion, even when passive, can exert a strong 
influence over someone, and consider passive coercion to be present when a person signs a 
consent form based on the belief that they do not have any other option. Whereas in contrast 
to this, Swift42 proposes that desperation does not affect capacity to consent but instead 
influences voluntariness, which in terms of informed consent is legally defined in relation to 
external constraints imposed by others in forms such as, coercion, undue influence, force or 
fraud. It is, however, important to note that in this study despite experiencing feelings of 
desperation and participants receiving support from loved ones throughout the decision-
making process, participants emphasised that they had perceived the decision to receive ECT 
as their own although, these decisions may not have been fully informed which in itself is a 
major ethical concern.  
 Throughout their narrative’s some participants understood their difficulties with 
depression as being caused or influenced by genetic factors or chemicals in the brain and this 
may have influenced their decision-making around whether to receive ECT. The notion that 
chemicals in the brain or genetic factors influence difficulties with depression sits in line with 
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a strong interpretation of the medical model of mental illness. This interpretation argues that 
mental illness is caused primarily by brain abnormalities, such as an imbalance in 
neurotransmitters, the presence of lesions or abnormal neural connectivity, and is therefore 
treatable exclusively by intervening in the brain or nervous system.43,44 By potentially having 
greater exposure to the medical model and understanding their difficulties in line with this 
explanation, participants may have been more likely to choose treatments which intervene in 
the brain, such as ECT, over other evidence-based treatments such as talking therapies, which 
are supported by the psychological model or biopsychosocial model of distress. It is, 
however, important to note that some individuals reported that they had not been offered 
alternative treatments such as talking therapies and may have therefore been denied the 
opportunity to engage in other evidence based treatments for depression, which have been 
described as being less intrusive and less “extreme” than ECT. Additionally, some 
individuals explained that they had limited opportunity to speak with clinicians about ECT, 
the mechanisms involved in the treatment and how these treat depression which further 
demonstrates that individuals may not have received sufficient information to make a fully 
informed choice around the treatment.   
 Participants shared their experiences at the time they had received ECT, their 
experiences following the treatment and their reflections. Participants consistently described 
experiencing initial feelings of anxiety and nervousness prior to them receiving ECT, which 
for some individuals was influenced by their previous experiences of ECT and negative 
portrayals of ECT presented by the media. However, such finding is likely not to be  
surprising as Chakrabarti et al.’s review paper45 reports that on average 63% of participants 
involved in research studies have reported feeling anxious or fearful before ECT. 
Nonetheless, participants described the support provided by clinicians as helpful and re-
assuring. All but one participant believed that they had found ECT helpful but emphasised 
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that it was “not an overnight success”. One individual, however, reported that she did not 
believe that ECT had improved her difficulties and therefore, declined her final scheduled 
treatment despite feeling under pressure from clinicians who were encouraging her to 
undergo this; a finding which highlights that decision-making around ECT is an ongoing 
process, particularly as a course of ECT on average consists of between six and eight 
treatments.  
 Memory difficulties following ECT were consistently understood by participants as 
one of the risks associated with the treatment and several individuals reported that their 
memory had worsened after the treatment. For some individuals, the memory difficulties they 
experienced following the treatment were viewed as less significant than their difficulties 
with depression. They, therefore, considered undergoing ECT to be worthwhile. However, 
one individual experienced extensive memory difficulties which significantly impacted her 
life and were problematic due to her familial circumstances. This individual wondered 
whether her decision around ECT would have been different if she had been aware of the true 
extent of her memory difficulties following ECT, rather than believing that her memory 
would only be affected on a short-term basis. Finally, participants held mixed views around 
whether they would opt to receive ECT again in the future, views which again were 
influenced by their difficulties prior to ECT, their experiences when receiving the treatment 
and their experiences following ECT, particularly experiences relating to memory difficulties 
and their previous difficulties with depression. Moreover, one participant wondered whether 
she would have needed ECT if more talking therapies had been available to her when she was 
younger.  
 
 
92 
Older Women’s Decision Making in the Context of Medical Treatments 
 
 
 
Clinical Implications and Recommendations for Clinical Practice 
 By exploring the narratives of older women who have been offered ECT and 
obtaining a greater understanding around their decision-making processes and factors which 
influence their decision-making, several clinical recommendations can be made to improve 
the support available for older women who experience mental health difficulties and older 
women who are faced with a decision around whether to receive ECT, in particular. It may be 
helpful for clinical services to utilise a clear model which highlights factors which influence 
the decision-making process experienced by individuals when they are offered ECT, such as 
the one outlined in Figure 1, as this is likely to positively influence the understanding of 
clinicians, which in turn may encourage more personalised discussions around ECT and 
improve the decision-making process for those offered the treatment. Moreover, as the impact 
of desperation has been discussed within the research literature in relation to its influence on 
an individual’s ability to make informed treatment choices clinical services should, therefore, 
ensure that they have robust and comprehensive consent procedures in place when supporting 
individuals throughout every treatment of ECT as findings from this research emphasised that 
decision-making around ECT is an ongoing process and individuals referred for the treatment 
are often, in essence, powerless in comparison to the impact of their difficulties. Ensuring 
that individuals are provided with accurate and accessible information relating to depression, 
factors which influence depression, available evidence based treatments and how these can be 
of benefit to individuals, the risks, benefits and mechanisms of ECT as well as how ECT 
‘works’, is just one aspect required within robust and comprehensive consent procedures as 
neglecting to provide such information significantly impacts an individual’s ability to provide 
informed consent and this in itself would be a serious ethical issue.  
 An additional recommendation relates to the use of in-depth cognitive assessments to 
explore an individual’s cognitive functioning prior to, during and following their treatment of 
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ECT. NICE guidance recommends that the cognitive functioning of individuals receiving 
ECT should be monitored on an ongoing basis and at a minimum at the end of each course of 
treatment.11 However, given the persistent and significant memory impairments associated 
with ECT and as research evidence suggests that older women are at greatest risk of harm 
from the treatment,8,19 the importance of thorough and ongoing cognitive assessment for this 
population, in particular, should be emphasised. Moreover, it feels important to provide 
individuals with information around rehabilitation opportunities and the support available to 
for individuals who experience cognitive difficulties, should cognitive assessments indicate 
that ECT has affected an individual’s cognitive functioning.  
 A final recommendation comes from the reflections of one participant who noted that 
throughout her decision-making it would have been helpful to talk to someone who had 
received ECT in recent years. It may, therefore, be helpful for clinical services to consider 
whether a peer support worker, who has lived experience around ECT, could support 
individuals who are considering whether to undergo ECT. Within the literature, people in 
recovery have experienced increased hope, an increased social network and increased 
motivation when supported by a peer support worker.46 Moreover, individuals have been 
found to build rapport more easily with peer support workers than with non-peer clinicians.46 
 
Strengths, Limitations and Recommendations for Future Research 
 As far as the author is aware, this research is the first study conducted in the UK to 
explore the decision-making processes experienced by women over sixty when they are 
offered ECT so therefore makes important contributions to the current literature exploring 
decision-making around whether to receive ECT. The findings highlighted the influence of 
several important factors which influence older women’s decision-making which, in turn, 
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have enabled the researcher to make several recommendations that are relevant for future 
clinical practice. It is, however, important to note that this study is not without its limitations. 
Despite initially aiming to explore the narratives of individuals who had been offered ECT, 
this study in fact only explored the narratives of women who had opted to receive ECT when 
they were aged sixty and over. The narratives and experiences of women who had declined 
ECT at the point they were offered the treatment were not captured in this research and this is 
likely to have significance as individuals who have received ECT appear to hold more 
favourable views around the treatment, than those who have declined ECT,45 although, the 
researcher notes that the seven participants interviewed as part of this study held varying 
views around ECT following the treatment. Also, due to the methods of recruitment 
individuals whose lead clinician believed that participating in the research would be too 
demanding due to their current physical, psychological or personal circumstances, were by 
default excluded from participating in the research. Similarly, several individuals who 
advised “they could not remember anything”, from that time in their life, those who believed 
that they “didn’t really have a choice” and individuals who had “found ECT frightening” 
were not willing to speak about their experiences around ECT. However, as one of the 
additional aims to the research was to improve the support available and the healthcare 
experiences of individuals offered ECT the researchers believed that interviewing individuals 
who were willing to speak about their experiences around ECT would best achieve their 
research aims whilst also reducing the risk of distress or harm through an individual’s 
involvement in the research process.  
 Throughout the research process the researcher had also been unable to share a 
written summary letter with one participant due to the individual experiencing significant 
physical health difficulties. This resulted in the researcher being unable to obtain feedback 
from the participant in relation to their understanding of the participant’s narrative. 
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Consequently, the interpretation of this participant’s narrative may have been influenced by 
the researchers own biases which, in turn, could have influenced the trustworthiness of the 
analysis despite the researcher taking additional steps to reduce the risk of bias.  
 A final limitation relates to the study’s small sample size, however, this supports the 
methodology utilised as NA is considered to be a useful qualitative methodology, particularly 
when sample sizes are small and where the focus of enquiry is upon the relationship between 
self and culture.33 Moreover, all but one of the seven participants recruited had, in the past, 
received care from one NHS Trust in England, which is likely to significantly influence the 
generalisability of this study’s findings as the decision-making processes of all but one 
participant is likely to be influenced by not only the personal views of individuals involved in 
their care, but also the availability of support and treatments within such Trust. Nonetheless, 
despite these limitations this research provides an important contribution to the current 
literature around older women’s decision-making around ECT by highlighting how 
individualised and highly personal such decision-making is. From the research findings 
several recommendations have been made which, should ECT continue to be available as a 
treatment for depression, could improve the support available to older women when they are 
faced with a decision around whether to receive the treatment Also, as the findings suggest 
that decision-making around ECT is highly personal, older women’s decision-making around 
mental health treatments is worthy of further exploration, particularly as the participants 
interviewed as part of this study held varying views around their treatment and experience 
preferences and the availability of mental health support. Moreover, as the present research 
specifically explores older women’s experiences of decision-making in ECT and as previous 
research has explored the perspectives of professionals,6 future research should complete the 
triangle of perspectives by seeking the views of family members and carers who support 
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individuals offered ECT, particularly as this study highlighted how the views of family 
members and friends can influence the decision-making of those offered ECT. 
 
Conclusions 
 Despite its limitations, as the only study conducted in the UK, this research provides 
an important contribution to the current literature around older women’s decision-making 
around ECT by exploring the personal narratives of seven women who had received ECT 
after they had become sixty years of age. The findings highlighted several key factors which 
influenced participants decision-making at the time they were offered ECT and emphasised 
the significant influence of participants difficulties and the impact of these. From the research 
findings several clinical recommendations have been made relating to the use of a clear 
model within clinical services to increase understanding around factors which influence 
decision-making around ECT, the use of robust and comprehensive consent processes 
throughout an individual’s course of ECT which ensure that individuals are provided with 
accurate and accessible information around ECT and alternative treatments for depression, 
and the frequent and consistent use of cognitive assessments. It is, therefore, felt that this 
study contributes to the growing body of literature which looks beyond individuals’ personal 
experiences of ECT and instead hopes to improve the decision-making process and support 
available for individuals faced with a decision around whether to undergo ECT.31 It is noted 
by the researchers that in the UK a group of professionals, individuals who have received 
ECT and carers are campaigning for ECT to be suspended and their request for an urgent 
review into the use of ECT has been supported by MIND, a leading mental health charity. 
However, whilst ECT continues to be offered as a treatment for depression we have a moral, 
ethical and professional responsibility to ensure that people are provided with clear, accurate 
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and accessible information and are supported throughout the decision-making process in a 
way that enables fully informed choice about what could be a life altering treatment. It is 
hoped that the recommendations made through the findings of this research will encourage 
more open discussions around ECT, will support a clinicians moral, ethical and professional 
responsibility, will facilitate more informed decision-making and will improve experiences 
for older women who are considering whether to undergo ECT.  
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Appendices 
 
Appendix A 
Author Guidelines for the Journal of Geriatric Psychiatry and Neurology 
 
1. What do we publish? 
1.1 Aims & Scope 
Before submitting your manuscript to Journal of Geriatric Psychiatry and Neurology, please 
ensure you have read the Aims & Scope. 
1.2 General Instructions 
Manuscripts should be submitted electronically to https://mc.manuscriptcentral.com/jgpn. 
Authors will be required to set up an online account on the SageTrack system powered by 
ScholarOne. Manuscripts will be sent out anonymously for editorial evaluation. Obtaining 
permission for any quoted or reprinted material that requires permission is the responsibility 
of the author. Submission of a manuscript implies commitment to publish in the journal. 
Authors submitting manuscripts to the journal should not simultaneously submit them to 
another journal, nor should manuscripts have been published elsewhere in substantially 
similar form or with substantially similar content. Authors in doubt about what constitutes 
prior publication should consult the Editor: James M. Ellison, MD, 
MPH, James.M.Ellison@ChristianaCare.org. 
Authors should keep for their own files a copy of all works submitted. Submission of a 
manuscript to the Journal of Geriatric Psychiatry and Neurology is taken as evidence that no 
portion of the text or figures have been copyrighted, published, or submitted for publication 
elsewhere unless information regarding previous publication is explicitly cited and 
permission obtained (a copy of such permission must be provided with the manuscript). 
All material (abstracts, keywords, text, tables, and figure captions) should be typed double-
spaced. Computer preparation is mandatory. Subheading should be used to designate the 
different sections of the text. References should be numbered consecutively throughout the 
text. Provide a list of three to six keywords to assist indexing of the article. 
Articles of any length are considered. 
Title page: The title should be brief and meaningful. The authors’ first and last names, 
academic or medical degrees, and affiliations should follow the title. Authorship should be 
limited to direct participants, although technical assistance can be acknowledged as a 
footnote. A separate paragraph should identify where the work was done, if supported by a 
grant or otherwise, and the meeting, if any, at which the paper was presented. 
Abstract: An abstract of approximately 150 words should be provided on. This abstract 
should be factual and should present the reason for the study, the main findings, and the 
principal conclusions. 
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Text: This should follow the usual format for scientific articles. Pages should be numbered 
consecutively. All abbreviations should be spelled out at first mention. Only generic names of 
drugs should be used. 
Figures and tables: Special care should be given to the preparation of figures and tables, 
including captions and explanatory information. Technical excellence is stressed. Lettering 
and arrows, where applicable, should be done in a professional manner. Color illustrations are 
unacceptable for publication without prior permission of the publisher. Recognizable 
photographs of patients must be masked and must carry with them written permission for 
publication. Captions for all figures should be typewritten double-spaced, with numbers 
corresponding to those on the figures themselves. 
Tables should be numbered consecutively according to their in-text citation. Each should be 
typed double-spaced and should be no larger than a single page. Include a brief descriptive 
title and an indication of its position in the text. 
References: Authors are responsible for correctness and completeness of references. 
References should be typed double-spaced on separate pages. They should be arranged 
according to their order of appearance in the text, and indicated by superscript numbers. 
References should be typed in accordance with the style shown below for book and journal 
articles. Up to four authors should be listed; when there are more than four, only the first 
three should be listed, followed by "et al." Abbreviations of journal names should conform to 
the style in Index Medicus. Abstracts, editorials, and letters to the editor should be noted as 
such. Personal communications, unpublished manuscripts submitted but not yet accepted, and 
similar unpublished items should not appear in the reference list. Such citations may be noted 
in the text. Some basic information regarding references and the reference list has been listed 
below. 
References List 
Basic rules for the reference list: 
• The title “References” is centered at the top of a separate page at the end of the document. 
• Entries are preceded by their number and are given in numerical order. 
• The reference list should be single-spaced. Single-space between entries. 
• The second line and all subsequent lines of each item in the reference list should be indented 
(hanging indent). 
• Do not use “et al.” in the Reference list at the end; names of all authors of a publication 
should be listed there. 
Here are a few examples of commonly found references. For more examples please check 
AMA (11th Ed). 
• Books Author(s) separated by commas. 
o Title of Book. Place of publication: Publisher; year. 
o Goldberg L, Elliot DL. Exercise for Prevention and Treatment of Illness. Philadelphia, Pa: 
FA Davis Co; 1994. 
• Edited book. 
o Author(s), eds. Title of Book. Place of publication: Publisher; year. 
o Armitage JO, Antman KH, eds. High Dose Cancer Therapy: Pharmacology, Hematopoietins, 
Stem Cells. Baltimore, Md: Williams & Wilkins; 1995. 
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• Chapter or article from a book Author(s) of article. 
o Title of article. In: Editor's name, ed. Title of Book. Place of publication: Publisher; 
Year: Chapter or page number. 
o Gamble VN. On becoming a physician: a dream not deferred. In: White EC, ed. The Black 
Women's Health Book: Speaking for Ourselves. Seattle, Wash: Seal Press; 1990:52-64. 
• Articles in journals 
o AMA style requires the use of standard abbreviations for all references, when applicable. 
Abbreviations for many common medical journals can be found in the AMA Manual of Style 
(pp.473-479). Additional abbreviations can be searched in the PubMed Journal Database 
(http://www.ncbi.nlm.nih.gov/nlmcatalog/journalbs). 
• One author (do not include issue number or month unless volumes are not consecutively 
numbered) 
o Author. Article title. Journal Title. Month Year;Volume:Inclusive page numbers. 
o Angelo J. A survey of persons who use integrated control devices. Assist Technol. 
1998;10:77-83. 
• Articles in Online Journals 
o The preferred citation style for an electronic journal uses a DOI (digital object identifier). The 
DOI provides a persistent link to the electronic item and is considered to be more stable than 
a URL. If the DOI is not given on the full text article or in the citation, use a DOI lookup tool 
to locate it (http://www.crossref.org/guestquery/) or use the format for an article without a 
DOI. 
• Article from online journals with DOI available. Note that when using a DOI, no access 
date or URL are used. 
o Author. Title of article. Name of Journal. Year;vol(issue):pages. doi:xx.xxxx. 
o Florez HR, Martinez RL. Outdoor exercise reduces the risk of hypovitaminosis D in the 
obese. J Steroid Biochem Mol Bio. 2007;103(3-5):679-681. doi:10.1016 
/j.jsbmb.2006.12.032. 
• Article from online journals without DOI available. The accessed date will often be the 
only date available. 
o Author. Title of article. Name of Journal. Year;vol(issue);pages. URL. Published date. 
Updated date. Accessed date. 
o Hay PJ. Understanding bulimia. Aust Fam Physician. 2007;36(9):708-
712. http://www.racgp.org.au/afp/200709/18554. Accessed October 11, 2009. 
• Web pages 
o Author or responsible body. Title of item cited. Name of website. URL. Published date. 
Updated date. Accessed date. 
o World Health Organization. Saving the future generation in Darfur. World Health 
Organization. http://www.who.int/features/2007/child_health/en/index.html. Published July 
7, 2007. Accessed October 11, 2009. 
• Other Media. Use for DVDs, videos, cd-roms, and other media formats. 
o Author. Title [format]. Publisher place: Publisher; Year. 
o Holzknect J. History of physical therapy in the United States [DVD]. New York, NY: Insight 
Media; 2007. 
IMPORTANT NOTE: To encourage a faster production process of your article, you are 
requested to closely adhere to the points above for references. Otherwise, it will entail a long 
process of solving copyeditor’s queries and may directly affect the publication time of your 
article. In case of any question, please contact the journal editor 
at James.M.Ellison@ChristianaCare.org. 
104 
Older Women’s Decision Making in the Context of Medical Treatments 
 
 
 
1.3 Writing your paper 
The SAGE Author Gateway has some general advice and on how to get published, plus links 
to further resources. 
1.3.1 Make your article discoverable 
For information and guidance on how to make your article more discoverable, visit our 
Gateway page on How to Help Readers Find Your Article Online 
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Appendix B  
Data Extracted from the Nine Studies Included in the Systematic Review 
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Interview Guide  
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Distress Protocol  
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